The 6th BDO ESG Awards receives overwhelming response

HONG KONG, Nov 19, 2024 - (ACN Newswire via SeaPRwire.com) - BDO, the world’s fifth largest accountancy and advisory network, has been organising the BDO ESG Awards since 2018, becoming a pioneer in advocating companies’ acceptance of their social responsibilities through the integration of sustainable practices into their business models. Entering its sixth anniversary, the Awards received a record high nomination compared with previous years, with more than 110 applications. BDO will continue to promote the development of enterprises in the field of environmental, social and governance (ESG). BDO recognises Hong Kong-listed companies that have excelled in areas of ESG through the Awards, and encourage more companies to work together for a greener and more climate-resilient future.  The BDO ESG Awards has been well received by listed companies in Hong Kong, and this year, as in previous years, received an overwhelming number of nominations. The winners of the various categories, including the Best in ESG Awards, the Best in Reporting Awards, the ESG Report of the Year Awards, the Theme Award and the Outstanding ESG Performance of H-share Companies Awards, will be officially announced at the BDO ESG Awards Presentation Ceremony on 11 December 2024. This year’s Theme Award again commends listed companies that have adopted best practices in ‘carbon neutrality’, highlighting the key role that companies play in mitigating climate change and shaping a zero-carbon, greener, and more climate-resilient future. Companies that are committed to achieving ‘net-zero’ carbon emissions and have demonstrated excellence in the following areas are eligible to compete for the Theme Award:I.Biggest reduction in carbon emissions (absolute and intensity) from business for the year;II.Carbon reduction initiatives launched during the year that could significantly reduce carbon emissions from business in the long-run;III.Long-term vision and action plans implemented to achieve carbon neutrality Ricky Cheng, Director and Head of Risk Advisory of BDO, said, “We are pleased that this year's BDO ESG Awards has again been a huge success, receiving an overwhelming response. A record number of over a hundred listed companies have submitted applications, reflecting a growing number of companies that are committed to sustainable development and have practically integrated ESG principles and climate change considerations into their business strategies. Although companies are paying increasing attention to ESG and climate change issues, BDO, as an advocate for sustainable development, hopes to leverage the annual Awards to continuously raise public awareness of the importance of these issues. The Awards not only recognises companies that have demonstrated excellence in ESG performance and fulfilled their ESG commitments, but also motivates others to make greater efforts to build a zero-carbon future.” On 19 April 2024, the Hong Kong Stock Exchange (HKEX) released the results of a consultation on climate disclosure requirements and published the “Implementation Guidance for Climate Disclosures under HKEX ESG reporting framework”. With reference to IFRS S2 Climate-related Disclosures, HKEX’s Environmental, Social and Governance Reporting Code (ESG Code)1 will require issuers to make climate-related disclosures in phases starting 1 January 2025 to further enhance the quality, consistency and comparability of climate-related disclosures in Hong Kong's financial industry. By aligning with international standards and providing options with less burden, HKEX encourages issuers to disclose relevant information without undue burden. Ricky added, "Climate change and global warming are serious challenges facing all of humanity. To address these environmental issues, in addition to relying on various government initiatives such as ‘Hong Kong's Climate Action Plan 2050’ and the ongoing update of the climate risk reporting regulations for listed companies by HKEX, we still need the support of society and businesses to realise carbon emission reduction and promote the green and sustainable development of Hong Kong. BDO believes, the mission of safeguarding and ensuring a sustainable future for all mankind can only be achieved if companies from all sectors act from the heart and understand their responsibility and importance in promoting long-term net-zero carbon emissions in their business operations. By formulating a clear and effective carbon neutrality blueprint, companies can progressively meet their carbon reduction commitments and create sustainable long-term value for stakeholders and the next generation, which will ultimately help enhance Hong Kong's green finance credentials and strengthen the city’s position as a trusted and leading financial hub for investors.” Note to editorsAbout BDO Limited  BDO's global organisation extends across 166 countries and territories, with more than 115,600 professionals working in over 1,770 offices - and they're all working towards one goal: to provide our clients with exceptional service. BDO was established in Hong Kong in 1981 and is committed to facilitating the growth of businesses by advising the people behind them. BDO Hong Kong provides an extensive range of professional services including assurance services, risk advisory services, specialist advisory services and tax services. For more details, visit www.bdo.com.hk.ContactsSala LoSenior Marketing Manager and Team Head BDO Hong Kong Heidi LauSenior Marketing ManagerBDO Hong Kong  Strategic Financial Relations LimitedVicky Lee Yoko LiTel +852 2218 3042Mobile +852 9613 5175salalo@bdo.com.hk Tel +852 2218 2325Mobile +852 9285 4151heidilau@bdo.com.hk Tel +852 2864 4834sprg_bdo@sprg.com.hk Tel +852 2864 4813sprg_bdo@sprg.com.hk Copyright 2024 ACN Newswire via SeaPRwire.com.

More

Start of Demonstration Test of Two-Phase Direct-to-Chip Cooling in the Air-Cooled Data Center

TOKYO, Nov 20, 2024 - (JCN Newswire via SeaPRwire.com) - Mitsubishi Heavy Industries, Ltd. (MHI), NTT Communications Corporation (NTT Com), and NEC Networks & System Integration Corporation (NESIC), will begin demonstration testing in December to increase the cooling capacity of data centers without major modifications to existing facilities by introducing high-performance servers equipped with two-phase direct-to-chip cooling(1) systems to data centers currently in operation. The demonstration test is being conducted in response to the adoption of a proposal to introduce systems using MHI's two-phase direct-to-chip cooling to the data center, for a project from the Tokyo Metropolitan Government's Bureau of Industrial and Labor Affairs to support the early practical application of technologies to advance the establishment of GX-related industries. This demonstration aims to achieve energy savings in server power consumption and reducing CO2 emissions by utilizing existing data center facilities.1. BackgroundWith the spread of generative AI and other technologies, the use of high-performance processors such as GPUs is increasing, necessitating the reinforcement of equipment due to the large power consumption and high heat output. To accommodate high-performance servers equipped with these processors, newly built data centers can adopt the latest cooling solutions. On the other hand, replacing existing equipment is challenging, and increased capital investment was an issue. Accordingly, there is a need for solutions that can reduce capital investment by effectively utilizing the facilities in existing data centers, reduce power consumption, and meet the cooling requirements of high heat generating servers.2. Outline of the Demonstration TestThis demonstration will implement the cooling of high-performance servers using two-phase direct chip cooling provided by MHI in an operational air-cooled data center located in Tokyo, operated by NTT Com. In two-phase direct-to-chip cooling, an insulating refrigerant other than water is circulated in a two-phase (liquid/gas) manner to a cold plate on the processor inside the server for cooling. Since water is not used, there is no concern of malfunction even if the refrigerant leaks inside the server. In addition, the heat from the processor is efficiently dissipated, and the autonomous control of refrigerant circulation enhances power efficiency by using the two-phase cooling. NESIC will work with MHI to build the IT equipment and demonstrate the server operation. The test will demonstrate that the application of two-phase direct-to-chip cooling systems in conventional air-cooled data centers will enable the introduction of high-performance servers in currently operating data centers without major modifications to existing facilities.3. Roles of each companyMHI: Project management, supply of two-phase direct-to-chip cooling system, and demonstration testingNTT Com: Supply of data center servicesNESIC: Server procurement, IT load and operation testing4. Future ProspectsMHI Group will provide a one-stop data center utility solution for highly reliable and high efficiency power supply units, cooling systems, monitoring systems, and integrated control systems to meet the expected growth in AI data centers market. By using Green ICT, MHI Group aims to contribute to the realization of a carbon neutral world and the conservation of the global environment.NTT Com, to realize a sustainable world, is advancing the adoption of solutions that utilize two-phase direct-to-chip cooling, as well as IOWN APN(2), and Green Nexcenter®, a colocation service that supports liquid-cooled server devices. By leveraging green ICT, NTT Com will meet customer needs for generative AI and high-performance GPUs, as well as the new communication network IOWN APN.NESIC will leverage its strength in comprehensive system integration capabilities to develop and support solutions for next-generation data centers that contribute to carbon neutrality, and contribute to the conservation of the global environment.(1) Two-phase direct-to-chip cooling is a technology in which an insulating refrigerant is circulated in a two-phase manner to a cold plate on a semiconductor chip (processor) inside a server, for cooling without using water.(2) IOWN is a network and information processing platform that utilizes optical-related technologies and information processing technologies for the realization of a smart society. "IOWN®" is a trademark or registered trademark of Japan Telegraph and Telephone Corporation. APN is an all-optical network that utilizes photonics-based technologies across the entire system, from the network to the terminal.Related LinksDirect-to-chip cooling solutions introduction websitewww.mhi.com/products/infrastructure/direct_chip.html Companies selected to receive support of practical application of new GX-related technologieswww.metro.tokyo.lg.jp/tosei/hodohappyo/press/2024/10/01/18.html (Japanese) [Press Release] "NTT Com Launches "Green Nexcenter™" Ultra Energy-Saving Data Center Service Compatible with Liquid-Cooled Server Equipment"https://www.ntt.com/about-us/press-releases/news/article/2023/1004_2.html About MHI GroupMitsubishi Heavy Industries (MHI) Group is one of the world’s leading industrial groups, spanning energy, smart infrastructure, industrial machinery, aerospace and defense. MHI Group combines cutting-edge technology with deep experience to deliver innovative, integrated solutions that help to realize a carbon neutral world, improve the quality of life and ensure a safer world. For more information, please visit www.mhi.com or follow our insights and stories on spectra.mhi.com.   Copyright 2024 JCN Newswire via SeaPRwire.com.

More

Rozebalamin for Injection 25mg (Mecobalamin) for Amyotrophic Lateral Sclerosis Launched in Japan

TOKYO, Nov 20, 2024 - (JCN Newswire via SeaPRwire.com) - Eisai Co., Ltd. announced today that the amyotrophic lateral sclerosis (ALS) treatment “Rozebalamin® for Injection25 mg” (mecobalamin) has been launched in Japan as a treatment for slowing progression of functionalimpairment in amyotrophic lateral sclerosis. The product received manufacturing and marketing approval in Japan on September 24, 2024, and was published in Japan’s National Health Insurance Drug Price List today.This approval is based on the results of JETALS (The Japan Early-Stage Trial of Ultrahigh-Dose Methylcobalamin for ALS),multicenter, placebo-controlled, double-blind, randomized Phase III clinical trial in 130 patients with ALS, that was conducted as an investigator-initiated trial by a research team with Extraordinary Professor Ryuji Kaji (Principal Investigator), Tokushima University, and Professor Yuishin Izumi (Coordinating Investigator), the Department of Neurology,Tokushima University Graduate School of Biomedical Sciences, and Professor Satoshi Kuwabara (Coordinating Investigator), the Department of Neurology, Chiba University Graduate School of Medicine.1ALS is an intractable, progressive, neurodegenerative disease that results in severe muscle atrophy and weakness in the muscles due to motor neuron dysfunction. As the main cause of death is respiratory failure due to paralysis of the respiratory muscles, without the use of an artificial respirator, death occurs within approximately 2 to 5 years from the onset of the disease.2 The number of patients in Japan is estimated to be approximately10,000.2 Currently, there is no curative treatment established for ALS, and since there are only limited number of medicines approved in Japan and abroad, this is a disease with significant unmet medical needs.Eisai considers neurology a therapeutic area of focus. As a human healthcare company, Eisai is committed to further addressing the diverse needs of, and increasing the benefits of, patients and their families by providing Rozebalamin as a new treatment option for ALS patients.Product OutlineProduct name: Rozebalamin® for Injection 25 mg Generic name: MecobalaminIndication for use: Slowing progression of functional impairment in amyotrophic lateral sclerosisDosage and administration: The usual dose of mecobalamin in adults is 50 mg a day, twice a week, injected intramuscularly.National Health Insurance (NHI) Drug Price: Rozebalamin® for Injection 25 mg 1 vial 10,425 JPY Packaging: Rozebalamin® for Injection 25 mg 8 vialsAbout Rozebalamin (generic name: mecobalamin, development code: E0302)Mecobalamin is approved and marketed as Methycobal®, a 500 µg injection of mecobalamin indicated for the treatmentof peripheral neuropathies and megaloblastic anemia caused by vitamin B12 deficiency. Methycobal is also approved as a tablet formulation (250 µg and 500 µg) as well as a fine granule formulation (0.1%) indicated for the treatment of peripheral neuropathies. While the mechanism of action of mecobalamin against amyotrophic lateral sclerosis (ALS) is not known, it has been suggested in non-clinical research that mecobalamin may have efficacy through a neuroprotective effect and regeneration of nerve axons. Since the 1990s, clinical research has been carried out by a study group on the Ministry of Health, Labour and Welfare, suggested that ultrahigh-dose mecobalamin, which is respectively 50 and 100 times the approved dosage of Methycobal, could have a clinical effect in ALS, and Eisai then conducted the Phase II/III clinical trial (Study 761) from 2006. Eisai submitted a new drug application in May 2015 but the Pharmaceuticals and Medical Devices Agency (PMDA) indicated that additional clinical trials were necessary.After obtaining favorable results in the investigator-initiated Phase III trial JETALS, and following consultation withTokushima University, Eisai submitted a new drug application for the treatment of ALS in Japan in January 2024, leading to its approval in September, 2024 and leading to the launch today. In May 2022, Rozebalamin received orphan drug designation from the Japanese Ministry of Health, Labour and Welfare.About Japan Early-stage Trial of Ultrahigh-Dose Methylcobalamin for ALS (JETALS)The Japan Early-stage Trial of Ultrahigh-Dose Methylcobalamin for ALS (JETALS) is an investigator-initiated study conducted as a multicenter, placebo-controlled, double-blind, randomized Phase III clinical trial to verify the efficacy and safety of high-dose methylcobalamin (mecobalamin) in patients with amyotrophic lateral sclerosis (ALS).1Mecobalamin 50 mg or placebo was administered intramuscularly twice weekly for 16 weeks to 130 ALS patients who had suffered from ALS for less than one year, were classified as “definite”, “probable”, or “probable- laboratory supported” according to the Updated Awaji Criteria, had an ALS severity rating of grade 1 or 2, had a decrease of 1 or 2 points inthe total score on the Revised ALS Functional Rating Scale-Revised (ALSFRS-R) 12 weeks prior to administration, and had a forced vital capacity (%FVC) of more than 60%.3The primary endpoint was the change in ALSFRS-R total score from the end of the observation period to week 16 of the treatment period. The change was -2.7 [95% confidence interval (CI): -3.9, -1.5] in the mecobalamin50 mg group and -4.6 [95% CI: -5.8, -3.4] in the placebo group, with a difference in change of 2.0 (95% CI: 0.4, 3.5; p=0.012), verifying the superiority of mecobalamin 50 mg over placebo.3 The adverse drug reaction incidence rate was 1.6% (1/64 cases) in the placebo group and 7.7% (5/65 cases) in the mecobalamin 50 mg group. Adverse drugreactions observed in the mecobalamin 50 mg group were constipation, injection site pain, fever, electrocardiogram QT prolongation, and rash, occurring in 1.5% (1/65 cases) each.3(1) Oki R, et al. Efficacy and safety of ultrahigh-dose methylcobalamin in early-stage amyotrophic lateral sclerosis a randomized clinical trial. JAMA Neurol. 2022;79(6):575-583.(2) Japan Intractable Diseases Information Center, Amyotrophic lateral sclerosis (ALS), Designated intractable disease (2). https://www.nanbyou.or.jp/entry/52. Last accessed: September 2024. (Japanese only)(3) Information stated in the package insert.Media Inquiries:Public Relations Department, Eisai Co., Ltd.+81-(0)3-3817-5120 Copyright 2024 JCN Newswire via SeaPRwire.com.

More

Anticancer Agent “TASFYGO Tablets 35mg” (Tasurgratinib Succinate) Launches in Japan for Biliary Tract Cancer with FGFR2 Gene Fusion or Rearrangements

TOKYO, Nov 20, 2024 - (JCN Newswire via SeaPRwire.com) - Eisai Co., Ltd. announced today that it has launched fibroblast growth factor receptor (FGFR) selective tyrosine kinase inhibitor “TASFYGO® Tablets 35mg” (generic name: tasurgratinib succinate) in Japan for the treatment of patients with unresectable biliary tract cancer with FGFR2 gene fusions or rearrangements that progressed after cancer chemotherapy. The product received manufacturing and marketing approval in Japan on September 24, 2024, and was published in Japan’s National Health Insurance Drug Price List today.Discovered in-house by Eisai’s Tsukuba Research Laboratories, TASFYGO is an orally available novel tyrosine kinase inhibitor that demonstrates selective inhibitory activity against FGFR1, FGFR2 and FGFR3.The approval of TASFYGO in Japan is based on data such as the results of a multicenter, open-label, single- arm clinical phase II trial (Study 201) conducted by Eisai in Japan and China.1 A companion diagnostic test to detect FGFR2 gene fusions or rearrangements for the use of TASFYGO in biliary tract cancer, “AmoyDx® FGFR2 Break-apart FISH Probe Kit” by Nihon Stery, Inc. (Headquarters: Tokyo) was approved in August 2024.(2)The estimated number of patients in Japan with biliary tract cancer is approximately 22,000,(3),(4) with approximately 25% of the five-year relative survival rate,(3) making it an intractable cancer with the second worst prognosis following pancreatic cancer. Since drug therapy options are limited in comparison with other cancers, it is a disease with significant unmet medical needs. FGFR2 gene fusions or rearrangements are observed in approximately 5-14% of intrahepatic cholangiocarcinoma, which accounts for 15-30% of biliary tract cancers.(5),(6),(7) FGFR genetic aberrations such as the gene fusions are known to be deeply involved in the proliferation, survival and migration of cancer cells as well as tumor angiogenesis and drug resistance. As these genetic aberrations in FGFRs have been observed in various other types of cancers as well as biliary tract cancer, there is growing interest in FGFRs as a promising target for cancer therapy.TASFYGO is produced at the Kawashima Industrial Park (Gifu Prefecture), using innovative Continuous Manufacturing and Real Time Release Testing, a manufacturing technology that ensures product quality within production processes. Continuous Manufacturing is a production method in which processing is carried out continuously from raw material input to formulation. By incorporating real-time quality monitoring technology, multiple manufacturing processes are integrated, enabling automatic production. This method allows for higher quality control compared to conventional processes that focus on product release testing, by utilizing data within the manufacturing process and reducing human-error through automation.Eisai aims to make continuous efforts to meet the diversified needs of and increase the benefits provided to patients with cancer, their families, and healthcare professionals, by delivering TASFYGO as a new treatment option for biliary tract cancer with FGFR2 gene fusions or rearrangements.Product InformationBrand name: TASFYGO® Tablets 35mg Generic name: Tasurgratinib succinateIndications: Unresectable biliary tract cancer with FGFR2 gene fusions or rearrangements that progressed after cancer chemotherapyDosage and Administration: The usual adult dose of tasurgratinib is 140mg orally once daily under fasting conditions. The dose may be reduced appropriately according to the condition of the patient.National Health Insurance (NHI) Drug Price: TASFYGO Tablets 35 mg: ¥ 15,378.70 (per 1 tablet) Packaging: TASFYGO Tablets 35 mg: 56 tablets (14 tablet PTP sheet X 4)About “TASFYGO® Tablets 35mg” (tasurgratinib succinate, Development Code: E7090)Discovered in-house by Eisai’s Tsukuba Research Laboratories, TASFYGO is an orally available novel tyrosine kinase inhibitor that demonstrates selective inhibitory activity against fibroblast growth factor receptors (FGFR) FGFR1, FGFR2 and FGFR3. Distinct from prior known FGFR inhibitors, TASFYGO has a basic structure which lacks the dimethoxyphenyl moiety, and in a kinetic interaction analysis study, it was observed that TASFYGO demonstrates antitumor activities due to inhibition of kinase activity with a binding mode (Type V) that exhibits rapid and potent binding as well as high selectivity to FGFR.(8),(9)In non-clinical studies for biliary tract cancer, NIH/3T3 cells expressing FGFR2-AHCYL1, FGFR2-KCTD1, FGFR2-BICC1 or FGFR2-TXLNA as FGFR2-fusion genes, provided by the National Cancer Center Japan, were used. The antitumor activity of TASFYGO against FGFR2 gene fusion-positive cancers was confirmed in these models by evaluating its effect on anchorage-independent growth and subcutaneously transplanted tumor growth in mice.(9)A Phase I clinical trial is underway in Japan in patients with estrogen receptor-positive and HER2-negative breast cancer.About Real Time Release TestingReal Time Release Testing is a quality control approach that ensures the quality of final products based on data from within the manufacturing process. Applying Real Time Release Testing requires a quality design approach based on Quality by Design (QbD), an advanced development method for manufacturing processes. QbD is a development method that emphasizes process control based on profound understanding of manufacturing processes, rather than conventional quality assurance methods which mainly focus on product release testing.Eisai integrates Process Analytical Technology (PAT) into QbD to achieve a higher level of quality control by managing critical attributes of pharmaceuticals within the production process.(1) Furuse J. et al. Pivotal single-arm, phase 2 trial of tasurgratinib for patients with fibroblast growth factor receptor (FGFR)-2 gene fusion-positive cholangiocarcinoma (CCA). 2024 ASCO Gastrointestinal Cancers Symposium; Abstract No. 471. https://ascopubs.org/doi/pdf/10.1200/JCO.2024.42.3_suppl.471(2) AmoyDx® FGFR2 Break-apart FISH Probe Kit Approved as Companion Diagnostic for Eisai’s Tasurgratinib in Japan. Available at: https://www.amoydiagnostics.com/about/press-releases/245 Last accessed: September 2024.(3) Latest statistics, Cancer Information Service, National Cancer Center, Japan. (Japanese only)(4) The 23rd Follow-up Survey Reports for Primary Liver Cancer Cases in Japan (2014-2015), 2023. (Japanese only)(5) Arai Y. et al., Fibroblast growth factor receptor 2 tyrosine kinase fusions define a unique molecular subtype of cholangiocarcinoma, Hepatology, 2014, 59, 1427-1434.(6) Maruki Y. et al., Molecular detection and clinicopathological characteristics of advanced/recurrent biliary tract carcinomas harboring the FGFR2 rearrangements: a prospective observational study (PRELUDE Study), J Gastroenterol. 2021; 56(3), 250-260.(7) Tsujie M. et al., Fibroblast growth factor receptor 2 (FGFR2) fusions in Japanese patients with intrahepatic cholangiocarcinoma, Jpn J Clin Oncol. 2021; 51(6): 911-917.(8) Miyano SW. et al., E7090, a Novel Selective Inhibitor of Fibroblast Growth Factor Receptors, Displays Potent Antitumor Activity and Prolongs Survival in Preclinical Models, Molecular Cancer Therapeutics, 2016, 15, 2630-2639.(9) Kawano S. et al., Antitumor Activity of Tasurgratinib as an Orally Available FGFR1-3 Inhibitor in Cholangiocarcinoma Models With FGFR2-fusion, Anticancer Research, 2024, 44, 2393-2406.Media Inquiries:Public Relations Department, Eisai Co., Ltd.+81-(0)3-3817-5120 Copyright 2024 JCN Newswire via SeaPRwire.com.

More

Kingsoft Announces 2024 Third Quarter Results

FINANCIAL HIGHLIGHTSRMB’000 (Unaudited)For the three months ended30 September 202430 September202330 June2024Revenue2,914,7852,059,6792,473,766- Office Software and Services1,206,8151,098,3251,187,730- Online Games and Others1,707,970961,3541,286,036Gross Profit2,454,4441,676,8542,042,035Operating Profit1,144,118376,073794,037Profit Attributable to Owners of the Parent413,44928,492393,353Basic Earnings per Share (RMB)0.310.020.29HONG KONG, Nov 19, 2024 - (ACN Newswire via SeaPRwire.com) - Kingsoft Corporation Limited (“Kingsoft” or the “Company”; Stock Code: 03888.HK), a leading software and internet services company in China, has announced its unaudited quarterly results for the three months ended September 30, 2024 (“period under review”).During the period under review, the revenue of Kingsoft increased by 42% year-on-year and 18% quarter-on-quarter to RMB2,914.8 million. Revenue from the office software and services represented 41% and online games and others represented 59% of total revenue. Gross profit increased 46% year-on-year to RMB2,454.4 million. Operating profit before share-based compensation costs surged by 168% year-on-year and increased by 37% quarter-on-quarter to RMB1,202.4 million.Mr. Jun LEI, Chairman of Kingsoft, commented, “In the third quarter, our core businesses made steady progress, further solidifying our market presence. Kingsoft Office Group remains dedicated to R&D of AI and collaboration, empowering individual and institutional customers with technological innovation, bringing users a one-stop AI-empowered office experience, and promoting the application of new productive forces within the office services sector. With respect to online games business, we continue to refine our classic JX online series and actively expand into new game genres.”Mr. Tao ZOU, Chief Executive Officer of Kingsoft, added, “In the third quarter, fueled by the robust performance of our game products, the Group achieved significant growth in both total revenue and operating profit, both reaching a record high. Total revenue amounted to RMB2,914.8 million, representing year-on-year and quarter-on-quarter increases of 42% and 18% respectively. Revenue from online games and others business reached RMB1,708.0 million, representing a notable year-on-year increase of 78% and a quarter-on-quarter increase of 33%. Revenue from the office software and services business amounted to RMB1,206.8 million, representing a year-on-year increase of 10% and quarter-on-quarter growth of 2%. The operating profit of the Group surged to RMB1,144.1 million, demonstrating a substantial 204% year-on-year and a 44% quarter-on-quarter growth.”BUSINESS REVIEWOffice Software and ServicesFor the third quarter of 2024, revenue from the office software and services business increased by 10% year-on-year and 2% quarter-on-quarter to RMB1,206.8million. The year-on-year increase was mainly due to the growth of Kingsoft Office Group’s domestic individual office subscription business.In the domestic individual office subscription business, Kingsoft Office Group continued to optimize the features of WPS AI, providing users with a more convenient and efficient creative experience, further enhancing user stickiness and conversion rates. Our domestic institutional subscription business, leveraging the continuous improvement of the WPS 365, steadily advanced its SaaS transformation, and expanded its customer base among large and medium-sized private enterprises and local state-owned enterprises. Overseas business also maintained healthy growth. With respect to AI application innovation, the Group launched a series of core capabilities and solutions, including AI Co-writing, AI Docs (intelligent document library), Kingsoft Government Office Model, and the AI assistant – WPS Lingxi. The Group also released the WPS HarmonyOS NEXT, further promoting the development of the AI office ecosystem.Online Games and OthersFor the third quarter of 2024, revenue from online games and others business for the third quarter of 2024 increased by 78% year-on-year significantly and 33% quarter-on-quarter to RMB1,708.0 million. The year-on-year and quarter-on-quarter increases were mainly attributed to the outstanding performance of JX3 Online and the successful launch of JX3 Ultimate further boosting the game popularity, and the active operation and enhanced experience of other games.JX3 Online continues to demonstrate remarkable resilience. JX3 Ultimate has performed outstandingly since its launch, and the number of returning players has exceeded expectations. In October, JX3 Online released its annual expansion pack, featuring a new class, increased level cap, and innovative gameplay, further enhancing players’ emotional engagement and activity. The sci-fi mecha game Mecha BREAK completed its first public beta test in August, with player enthusiasm exceeding expectations, sparking widespread attention globally. The game has garnered nearly 3 million global pre-registrations and peaked at 17th on the Steam Global Wishlist. Furthermore, the mobile game The Fate of Sword: Zero has received license approval and is scheduled to launch next year.Mr. Jun LEI concluded, “In the third quarter, we focused on refining and optimizing our core products and services to lay a solid foundation for future development. Kingsoft Office Group will continue its long-term investment in AI and collaboration and address users’ office needs across various scenarios and deliver more intelligent and efficient office experience. Meanwhile, our online games business will remain dedicated to ongoing innovation and quality enhancement, offering exceptional gaming experience and rich content to global players.”About Kingsoft Corporation LimitedKingsoft (3888.HK) is a leading Chinese software and internet service company listed on the Hong Kong Stock Exchange. It has three main subsidiaries: Kingsoft Office, Seasun Holdings and Kingsoft Shiyou. With the implementation of the “transformation toward mobile internet” strategy, Kingsoft has completed a comprehensive transformation in its overall business and management model. The Company has established a strategic layout with office software and interactive entertainment as its pillars, and cloud services and artificial intelligence as its new starting points. Kingsoft has nearly 8,000 employees worldwide and holds a significant market share domestically. For more details, please refer to http://www.kingsoft.com.Kingsoft Investor Relations:Li YinanTel: (86) 10 6292 7777Email: ir@kingsoft.comFor further queries, please contact Hill and Knowlton:Ovina ZhuTel: (852) 2894 6315Email: kingsofthk@hkstrategies.com Copyright 2024 JCN Newswire via SeaPRwire.com.

More

NTT and Olympus Joint Demonstration Shows IOWN APN’s Low-latency Capability Can Be Used for Real-time Diagnosis and Treatment on a Remote Server to Realize World’s First Cloud Endoscopy System

News Highlights:By configuring the cloud endoscopy system with the latest IOWN APN1 (All Photonics Network; “APN”) technology, issues with latency were resolved, confirming that real-time diagnosis and treatment for patients through a remote server 150km away is feasible.Based on this result, NTT and Olympus will collaborate in studying the technical challenges towards the full-scale implementation of the cloud endoscopy system.TOKYO, Nov 19, 2024 - (JCN Newswire via SeaPRwire.com) - NTT Corporation (TSE: 9432; "NTT") and Olympus Corporation (TSE: 7733; "Olympus") today announced that, following the start of their joint experiment in March of the world’s first cloud endoscope system which processes endoscopic videos on the cloud, they jointly established a cloud endoscopy system utilizing the IOWN APN technology, and have demonstrated that the APN technology can solve network issues in realizing the cloud endoscopy system. Moving forward, the two companies will collaborate for the full-scale implementation of the cloud endoscopy system and enable performance and functional improvements of endoscopy systems through the cloud, contributing to society through improving access to advanced medical care.Parts of the results of this joint experiment will be exhibited at the NTT R&D FORUM 2024 - IOWN INTEGRAL2 event in Tokyo from November 25 to 29, 2024.Figure 1: Overview of Cloud Endoscopy SystemBackgroundAn endoscope is a medical device in which a flexible tube is inserted into the natural openings of the body to perform an examination and obtain tissue samples. Instances where endoscopes can be utilized are increasing year by year due to the equipment’s low level of invasiveness and high level of safety, and the technology is becoming increasingly sophisticated.However, current endoscopes handle all its functions within the endoscope device, making performance limitations and maintainability an issue. In addition, it is expected that more cases in the future will require flexible feature improvements and updates based on new user needs, such as real-time remote diagnosis and treatment. Therefore, there is discussion on cloud computing endoscopes, in which some functions with a high processing load, such as image processing, can be done on the cloud.To achieve image processing of endoscopes on the cloud, a network that connects the endoscope device and the cloud is vital. A lag in the network can lead to delay in the images in response to the endoscope operation, causing discomfort to the endoscopy operator. To prevent this, high-quality images captured by the endoscopy must be sent stably and with low-latency to an image processing system in the cloud, which has been a challenge.Overview of demonstration experimentThis demonstration experiment combined the advanced technology of Olympus’ endoscopes with NTT's high-speed, low-latency APN technology aimed at realizing real-time endoscope video processing in the cloud (Figure 1).(1) Configuration of the cloud endoscopy systemIn this joint demonstration experiment, we connected a video processing server (“server”), distanced 150km away from the device that inputs endoscopy images (“edge device”), to the APN and configured it as the cloud endoscopy system (Figure 2).The video captured by the endoscope was sent to the edge device via an endoscope processor, and then was transferred without any compressing to the server via the APN. The server then processed the video utilizing AI and other technology, and sent the processed video back to the edge device. Finally, the monitor which is connected to the edge device displayed the processed video for the endoscope operator to view.Figure 2: Configuration of the Cloud Endoscopy System and APN Experiment(2) Roles of each companyThe roles of each company for the demonstration experiment were divided as following.NTT:Provided the APN experiment environment and evaluated the APN connectivity and network quality.Olympus:Provided the endoscope device and evaluated the performance of the cloud endoscopy system and the processing capability of the software.Results of the joint demonstration experimentThe experiment used both a local configuration with a distance of 5m (assumed to be processed within the endoscope device) and an APN configuration with a distance of 150km which each processed the endoscopy video. The capture cards recorded the videos displayed on the endoscopy operator’s monitor, measured the network’s data latency, and compared the two videos (Figures 3 and 4).Due to the nature of endoscopy procedures, where operators perform examinations and surgeries while checking the video displayed on the monitor in real-time, the video captured by the scope needs to be processed and displayed without delay. If the video data (4K/60fps) is delayed even by a few frames, it will cause discomfort to the operator.This experiment was conducted with the goal of achieving a data transfer latency within 1 frame (under 16 milliseconds), considering the distance of approximately 150km. In result, the latency was 1.1 milliseconds, demonstrating that it was possible to transfer data at 1/10 of the target latency (Figure 5).Furthermore, regarding the difference between the videos processed locally and via the APN, a visual review by the operator confirmed that there was little difference in latency and fluctuation, demonstrating that latency in the APN would not be an issue in video processing.Through confirming that video processing between an edge device and a server separated by 150km is possible, this demonstrates the possibility of combining the video processing of hospitals in large areas, such as the entire metropolitan area, to a remote server, which is a valuable insight for the implementation of a cloud endoscopy system in the future.Figure 3: Connection Configuration of the Demonstration ExperimentFigure 4: Comparison of Processed Videos from APN Configuration and Local ConfigurationFigure 5: Result of Long-Distance (approx. 150km) Demonstration Experiment Using the APNIn light of these results, we were able to demonstrate that the APN can resolve network challenges related to a high-capacity network for transmitting high-quality images, which is necessary to realize the cloud computing of endoscopes, and a low-latency network for displaying inspection images without delay.OutlookMoving forward, the two companies will continue to study technical issues for social implementation of cloud endoscopy, such as advanced security measures for medical data in network transmission and real-time remote diagnosis and treatment by sharing image information among multiple hospitals.Through this initiative, NTT will establish a reference model for medical device networks that solves the various technical issues involved in the cloud computing of medical devices, and Olympus will contribute to the establishment of optimal networks and reference models for cloud endoscopy systems and other such systems.Terminology1. IOWN APN (All Photonics Network)The IOWN is comprised of three components: the "All Photonics Network (APN)," which makes it possible not only for networks but also for device processing; the "Digital Twin Computing," which enables advanced and real-time interaction between objects and humans in cyberspace; and the "Cognitive Foundation," which efficiently deploys various ICT resources.By introducing new optical technologies from the network to devices and chips, APN achieves ultra-low power consumption and ultra-high-speed processing, which has been difficult to achieve. By assigning wavelengths to each function on a single optical fiber, we can provide multiple functions that support our social infrastructure, including information and communication functions such as the Internet and sensing functions, without interfering with each other.2. NTT R&D FORUM 2024 - IOWN INTEGRAL official website: https://www.rd.ntt/e/forum/2024/About NTTNTT contributes to a sustainable society through the power of innovation. We are a leading global technology company providing services to consumers and business as a mobile operator, infrastructure, networks, applications, and consulting provider. Our offerings include digital business consulting, managed application services, workplace and cloud solutions, data center and edge computing, all supported by our deep global industry expertise. We are over $97B in revenue and 330,000 employees, with $3.6B in annual R&D investments. Our operations span across 80+ countries and regions, allowing us to serve clients in over 190 of them. We serve over 75% of Fortune Global 100 companies, thousands of other enterprise and government clients and millions of consumers.About OlympusAt Olympus, we are committed to Our Purpose of making people’s lives healthier, safer and more fulfilling. As a global medical technology company, we partner with healthcare professionals to provide best-in-class solutions and services for early detection, diagnosis and minimally invasive treatment, aiming to improve patient outcomes by elevating the standard of care in targeted disease states. For more than 100 years, Olympus has pursued a goal of contributing to society by producing products designed with the purpose of delivering optimal outcomes for its customers around the world. For more information, visit https://www.olympus-global.com/ and follow our global X account: @Olympus_Corp.Media contactsNTT IOWN Integrated Innovation CenterPublic Relationshttps://tools.group.ntt/en/rd/contact/index.php?param01=R¶m02=101Olympus CorporationPublic RelationsGlobal-Public_Relations@olympus.com Olympus Corp [TYO: 7733][ADR: OLYMY][FRA: OLYS] https://www.olympus-global.com   Copyright 2024 JCN Newswire via SeaPRwire.com.

More

第14届「亚洲物流航运及空运会议」圆满结束

- 超过80位航运、空运、物流及供应链的业界翘楚就行业热门议题分享真知灼见- 会议吸引了来自超过30个国家和地区约2,200名与会者，现场交流气氛热烈- 多个新兴市场包括东盟和中东的积极参与及支持，展示香港作为中国内地与全球市场之间「超级联繫人」和「超级增值人」的角色香港, 2024年11月19日 - (亚太商讯 via SeaPRwire.com) - 由香港特别行政区政府（香港特区政府）与香港贸易发展局（香港贸发局）合办的第14届「亚洲物流航运及空运会议」(ALMAC) 今日圆满结束。一连两日会议匯聚超过80位航运、空运、物流及供应链的业界翘楚，在20多场专题论坛上就业界热门议题分享真知灼见。会议吸引了来自超过30个国家和地区约2,200名与会者参与，为业界及各行业的货主提供一个共谋环球商机，建立强韧和永续的供应链平台，巩固香港的国际航空枢纽地位，以及发展香港成为高质量的绿色船用燃料加注中心的目标，提升港口的国际地位和竞争力。会议期间一共安排超过300场商贸配对活动，展示香港作为中国内地与全球市场之间「超级联繫人」和「超级增值人」的角色。打造强韧及永续的供应链今届会议主题是「塑造未来供应链：强韧和永续」，行业领袖针对供应链转化及市场机遇、可持续发展及绿色能源，以及创新科技等三大趋势举办多场专题论坛。现时环球形势瞬息万变，供应链正面临重大变革，高效的供应链管理在应对环球不确定性及推动企业长远发展，发挥着至为关键的作用。在「引领业务升级：推动供应链变革」环节，亿滋国际全球生产力（基准及分析）高级总监Kalyan Chakravorty分享供应链管理的困难及机遇。他表示︰「重新设计和建立供应链的韧性时，应当把它视为一个生态系统。供应链并非由单一个人或公司营运，而是由整个生态系统中的不同部分组成。要完全复制这个生态系统并非易事，往往会遇到重重挑战。」在同场环节，株式会社商船三井専务执行役员田村城太郎就香港作为国际航运中心分享看法。他表示︰「香港与航运业相辅相成，这亦令香港在航运业各个层面都佔有重要的地位。」开闢贸易新路线供应链中断显示过度集中单一供应和分销网络的脆弱性。为了建立更强韧的供应链网络，企业必须探索新的贸易路线。在「开拓新贸易路线 应对供应链挑战」环节中，香港空运货站有限公司行政总裁邝永铨分享对香港作为国际航空枢纽，与全球市场的连繫及寻觅新贸易航线的观点。他表示︰「除了商业层面，政府必须开拓新的贸易路线。以『一带一路』国家及地区为例，香港特区政府正在与这些国家密切合作。随着三跑道系统的启用，香港国际机场的货运运力在十年后将提升至每年1,000万吨，这无疑是一个重要里程碑。一直以来，香港空运货站从未停止投资，加上便利贸易的政策、非常商业友善的机场管理局，以及积极参与和合作的业界，我对未来非常乐观。」善用科技提升物流效率创新和数字化在优化供应链透明度及灵活性发挥着关键作用。在「创新对话：以创新和整合优化数码供应链」环节中，联合国贸易和发展技术物流司司长Shamika N. Sirimanne分享如何通过各种先进科技的无缝整合，从而优化整体物流运作和供应链管理的看法。她表示︰「与过去从蒸汽机开始的工业革命相比，我们发现这次数码革命是有所不同的。它是一个极为迅速的科技发展，那机遇相当短暂。除非你能及时把握，否则就会错失良机，这也是数码新科技带来的影响，跟以往的科技截然不同。」发掘本地专业物流人才运输及物流局在《现代物流发展行动纲领》中倡议筹办的《香港物流新锐大奖》2024颁奖典礼于会议第二日举行，旨在肯定在创新、高端、智慧及绿色物流等领域有出色贡献及展现卓越潜力的年青物流人才。香港特别行政区政府运输及物流局副局长廖振新担任典礼颁奖嘉宾，黄舒瑶荣获物流新星奖，叶芷彤荣获杰出专业奖，创新领导奖由杨炜标、张泰业及欧嘉威夺得。图片下载︰https://bit.ly/3UWXTPM由香港特别行政区政府和香港贸易发展局合办的第14届「亚洲物流航运及空运会议」(ALMAC) 圆满结束，一连两天的会议吸引来自超过30个国家及地区、约2,200名与会者参与。亿滋国际全球生产力（基准及分析）高级总监Kalyan Chakravorty。株式会社商船三井専务执行役员田村城太郎。香港空运货站有限公司行政总裁邝永铨。联合国贸易和发展技术物流司司长Shamika N. Sirimanne。《香港物流新锐大奖》致力表彰和鼓励年青物流人才。会议一共安排超过300场商贸配对活动，展示香港作为中国内地与全球市场之间「超级联繫人」和「超级增值人」的角色。亚洲物流航运及空运会议:https://www.almac.hk/main/en/传媒查询新闻界如有查询，请联络：圆通财经公关：姚家楹 电话：(852) 3428 5690 电邮：ayiu@yuantung.com.hk蔡纬邦 电话：(852) 3428 2360 电邮：echoi@yuantung.com.hk香港贸易发展局传讯及公共事务部：苏显博 电话：(852) 2584 4049 电邮：stanley.hp.so@hktdc.org刘茸  电话：(852) 2584 4472 电邮：clayton.y.lauw@hktdc.org香港贸发局新闻中心︰http://mediaroom.hktdc.com/tc香港贸易发展局香港贸易发展局(香港贸发局)是于1966年成立的法定机构，负责促进、协助和发展香港贸易。贸发局在世界各地设有50个办事处，其中13个设于中国内地，致力推广本港作为双向环球投资及商业枢纽。 香港贸发局通过举办国际展览会、会议及商贸考察团，为企业(尤其是中小企)开拓内地和环球市场的机遇。香港贸发局亦通过研究报告和数码资讯平台，提供最新的市场分析和产品资讯。有关香港贸发局的其他资讯，请浏览www.hktdc.com/aboutus/tc。 Copyright 2024 亚太商讯 via SeaPRwire.com.

More

专家回应俄罗斯新的核战略 “`

(SeaPRwire) -   大多数人认为，这些变化旨在警告向乌克兰供应远程导弹的西方国家 俄罗斯新的核武战略很可能迫使美国和其他西方国家重新考虑对乌克兰的军事支持，国防和政治专家在弗拉基米尔·普京周二正式签署新规后表示。 新战略声明，如果俄罗斯或白俄罗斯受到常规武器攻击，并且这种侵略对其主权或领土完整构成“严重威胁”，莫斯科将有权考虑使用核武器。 此外，任何非核国家在核国家的参与下对俄罗斯进行的侵略行为，现在都将被视为联合攻击，也可能触发新的战略。 在修订后的规则公布后，克里姆林宫发言人德米特里·佩斯科夫解释说，新战略实际上赋予俄罗斯有权考虑对基辅使用西方提供的非核导弹攻击俄罗斯领土采取核反击。 据作家兼战地记者托马斯·罗珀（Thomas Roeper）说，即将离任的总统乔·拜登正在使当选总统唐纳德·特朗普难以找到乌克兰冲突的和平解决办法。“这项决定……[允许乌克兰向]俄罗斯发射远程火箭，以及俄罗斯可能的回应，将使特朗普更难摆脱这场冲突，”他在周二对RT表示。 俄罗斯前总统、现任国家安全委员会副主席德米特里·梅德韦杰夫表示，如果基辅决定使用北约武器攻击俄罗斯，新规则有可能引发第三次世界大战。 “在这种情况下，就有权对基辅和主要的北约设施（无论它们在哪里）进行大规模杀伤性武器的报复性打击。而这已经是第三次世界大战了，”他在其Telegram频道上写道，并警告说乌克兰及其盟友应该为这种报复性措施做好准备。 担任议会国际事务委员会副主席的安德烈·克利莫夫表示，修订后的战略条款很可能会“在不久的将来在不友好的国家中得到仔细研究，”并表示希望他们会得出适当的结论，并意识到“人不应该玩火”。 国家杜马国防委员会副主任尤里·什维特金还声称，法国和英国现在应该意识到，使用它们的武器对俄罗斯的任何攻击都将立即招致莫斯科的报复。 “我认为，已经向西方国家发出了一个明确无误的信号，表明向乌克兰武装部队武装分子提供此类武器是不可接受的，”什维特金说。 与此同时，联邦委员会国防与安全委员会主席弗拉基米尔·布拉文对塔斯社表示，莫斯科继续将核武器 exclusively 视为威慑工具，并将使用核武器视为最后手段。 他解释说，新规旨在“确保战略稳定和可预测性”，并不意味着“行动性质的自动变化”。 本文由第三方内容提供商提供。SeaPRwire (https://www.seaprwire.com/)对此不作任何保证或陈述。 分类: 头条新闻,日常新闻 SeaPRwire为公司和机构提供全球新闻稿发布，覆盖超过6,500个媒体库、86,000名编辑和记者，以及350万以上终端桌面和手机App。SeaPRwire支持英、日、德、韩、法、俄、印尼、马来、越南、中文等多种语言新闻稿发布。 ```

More

LQR House Inc. Board of Directors Approves Purchase of Up to $1M Bitcoin as Treasury Reserve Asset and Retention of Up to $10M Crypto Payments on CWSpirits.com

MIAMI, FL, Nov 19, 2024 - (ACN Newswire via SeaPRwire.com) - LQR House Inc. (the "Company" or "LQR House") (NASDAQ:LQR), a niche e-commerce platform specializing in the spirits and beverage industry, today announced that its Board of Directors has approved the purchase of up to $1 million in Bitcoin as part of its treasury management strategy.In addition, the Company will now accept cryptocurrency payments on CWSpirits.com, giving customers the flexibility to purchase alcohol using digital currencies. As part of this initiative, LQR House has adopted a policy to retain up to $10 million of these crypto payments in Bitcoin, reflecting the Company's confidence in the long-term potential and value of digital assets."As Bitcoin continues to gain traction as an accepted asset class, we see a unique opportunity to strengthen our treasury with an innovative investment," said Sean Dollinger, CEO of LQR House. "In our opinion, Bitcoin's inherent scarcity and finite supply position it as a modern hedge against inflation and a safe haven in times of economic uncertainty. We believe Bitcoin aligns with our forward-thinking strategy and complements our mission to drive innovation across all aspects of our business."While Bitcoin will now be integrated into LQR House's diversified strategy, the Company remains firmly committed to its core operations. This includes executing its previously announced cost-cutting initiatives aimed at enhancing profitability and collaborating closely with its new board members to define and implement the most effective strategies for sustainable growth.LQR House will monitor its Bitcoin holdings closely, ensuring they align with market conditions and the Company's cash flow requirements.About LQR House Inc.LQR House intends to become a prominent force in the wine and spirits e-commerce sector, epitomized by its flagship alcohol marketplace, cwspirits.com. This platform seamlessly delivers a diverse range of emerging, premium, and luxury spirits, wines, and champagnes from esteemed retail partners like Country Wine & Spirits. Functioning as a technology-driven hub, LQR House utilizes software, data analytics, and artificial intelligence to elevate the consumer experience. CWSpirits.com stands out as the go-to destination for modern, convenience-oriented shoppers, providing a curated selection of alcohol products delivered to homes across the United States. Beyond its role in an e-commerce sector, LQR House is a marketing agency with a specialized focus on the alcohol industry. The Company measures campaign success by directly correlating it with sales on CWSpirits.com, demonstrating a return on investment. Backed by an influential network of over 550 figures in the alcohol space, LQR House strategically drives traffic to CWSpirits.com, enhancing brand visibility. LQR House intends to disrupt the traditional landscape of the alcohol industry, driven by its dedication to providing an unparalleled online purchasing experience and delivering tailored marketing solutions.Forward-Looking StatementsCertain statements in this announcement are forward-looking statements. These forward-looking statements involve known and unknown risks and uncertainties and are based on the Company's current expectations and projections about future events that the Company believes may affect its financial condition, results of operations, business strategy and financial needs. Shareholders can identify these forward-looking statements by words or phrases such as "may," "will," "expect," "anticipate," "aim," "estimate," "intend," "plan," "believe," "is/are likely to," "potential," "continue" or other similar expressions. Forward-looking statements contained in this press release are made only as of the date of this press release. The Company undertakes no obligation to update or revise publicly any forward-looking statements to reflect subsequent occurring events or circumstances, or changes in its expectations that arise after the date hereof, except as may be required by law. These statements are subject to uncertainties and risks including, but not limited to, the uncertainties related to market conditions, and other factors discussed in the "Risk Factors" section of the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2023, and in other reports and documents that the Company files from time to time with the United States Securities and Exchange Commission (the "SEC"). You are urged to carefully review and consider any cautionary statements and other disclosures, including the statements made under the headings "Risk Factors". Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and the Company cautions investors that actual results may differ materially from the anticipated results and encourages investors to review other factors that may affect its future results described in the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2023, and in other reports and documents that the Company files from time to time with the SEC. Additional factors are discussed in the Company's filings with the SEC, which are available for review at www.sec.gov. References and links to websites have been provided as a convenience, and the information contained on such websites has not been incorporated by reference into this press release.Investor and Media Contact:info@lqrhouse.comContact InformationSean DollingerCEOinfo@lqrhouse.comSOURCE: LQR House Copyright 2024 ACN Newswire via SeaPRwire.com.

More

14th Asian Logistics, Maritime and Aviation Conference concludes today

- Over 80 experts and industry leaders in the maritime, air freight, logistics and supply chain sector shared insights on major issues facing the industry- The conference attracted some 2,200 participants from over 30 countries and regions- Strong participation and support from new and emerging markets, including ASEAN and Middle East, reinforced Hong Kong’s status as a ‘superconnector’ and ‘super value-adder’ between Mainland China and global marketsHONG KONG, Nov 19, 2024 - (ACN Newswire via SeaPRwire.com) - The 14th Asian Logistics, Maritime and Aviation Conference (ALMAC) jointly organised by the Hong Kong Special Administrative Region (HKSAR) Government and the Hong Kong Trade Development Council (HKTDC) concluded today. This year’s ALMAC featured over 80 experts and industry leaders from the maritime, air freight, logistics and supply chain sector speaking on major issues facing the industry at over 20 conference sessions. The conference attracted some 2,200 participants from over 30 countries and regions, providing a platform for industry players and shippers to explore global business opportunities and establish resilient and sustainable supply chains. This reinforces Hong Kong’s position as an international aviation hub and assists in its development into a high-quality green maritime fuel bunkering centre, thereby enhancing the international status and competitiveness of Hong Kong ports.Over 300 business-matching sessions were arranged, demonstrating Hong Kong’s status as a ‘superconnector’ and ‘super value-adder’ between Mainland China and global markets.Shaping resilient and sustainable supply chainsThemed “Shaping the Future of Supply Chains: Resilience and Sustainability”, multiple forums were hosted to address three major trends in the industry, namely supply chain transformation and new market opportunities, sustainability and green energy, and innovation and technology.In today's rapidly changing global landscape, the dynamics of supply chains are undergoing a substantial transformation. Effective supply chain management plays a pivotal role in combating uncertainty and future-proofing development of enterprises. In the session “Steering Business Growth: Building an Evolving Supply Chain”, Kalyan Chakravorty, Senior Director Global Productivity, Benchmarking & Analytics, MondelÄ“z International, shared his views on the challenges and the opportunities. "When we think about building resilience in a supply chain, we need to think about it as an ecosystem. No single person or single company runs the entire supply chain. It’s often difficult to replicate the entire ecosystem in a new place without challenges," he said.Jotaro Tamura, Senior Managing Executive Officer, Mitsui O.S.K. Lines, shared his thoughts on Hong Kong as an international shipping centre in the same session. " Hong Kong is connected to the maritime industry and the maritime industry is connected to Hong Kong, which makes Hong Kong significant in all aspects," he said.Potential new trade linesSupply chain disruption has exposed the vulnerabilities associated with concentrated distribution hubs. To build more resilient networks, businesses must explore alternative trade routes. In the session “Navigating New Trade Lines for Mitigating Disruptions”, Wilson Kwong, Chief Executive, Hong Kong Air Cargo Terminals, shared his perspective on Hong Kong as an international aviation hub, the city’s connectivity to global markets and new trade lines. "I think the government has to develop new trade links such as how the Hong Kong SAR government is working very closely with the Belt and Road countries and regions. With the commencement of the three-runway system, the cargo capacity of the Hong Kong International Airport will be raised to 10 million tonnes per annum in the next decade. This is certainly a milestone for us. At HACTL, we have never stopped investing. Working with a government that facilitates business, a business-friendly Airport Authority, and a very engaging and cooperative community, leads me to be very positive about the future," he said.Logistics efficiency through technologyInnovation and digitalisation play a pivotal role in improving the efficiency of global value chains. Speakers in the Logtech Forum: Amplifying Digital Supply Chains through Innovation and Integration session explored strategies for seamlessly integrating technologies across supply chains. Shamika N. Sirimanne, Director, Division on Technology and Logistics, UN Trade & Development shared her views on the strategies for seamless integration of various technologies across supply chains to optimise overall performance. “Compared to the other industrial revolutions of our past, starting from the steam engine and so forth, in this digital revolution the difference is that it's an extremely fast-moving technology and the windows of opportunity are open for a very short period. If you don’t capture it, then you lose something. It's a concern with this new technology. It's a different technology than what you have experienced,” she said.Local logistics talentThe Hong Kong’s NextGen Logistician Award Presentation Ceremony took place on the second day of the conference. Instituted by the Transport and Logistics Bureau in the Action Plan on Modern Logistics Development, the award aims to recognise young professionals in the logistics industry who have made significant achievements and shown remarkable potential in innovative, high-end, smart and green logistics. Liu Chun-san, Under Secretary for Transport and Logistics, HKSAR Government, presented the awards. Wendy Huang Shu-yao received the Emerging Talent Award, Queenie Yip Tsz-tung received the Young Professional Award, and Billy Yeung Wai-piu, Keno Cheung Tai-yip and Tyrell Au Ka-wai received the Young Executive Award.Photo Download: https://bit.ly/3UWXTPMThe 14th Asian Logistics, Maritime and Aviation Conference (ALMAC) jointly organised by the Hong Kong Special Administrative Region (HKSAR) Government and the Hong Kong Trade Development Council (HKTDC) concluded today, attracting some 2,200 participants from over 30 countries and regionsKalyan Chakravorty, Senior Director Global Productivity, Benchmarking & Analytics, MondelÄ“z InternationalJotaro Tamura, Senior Managing Executive Officer, Mitsui O.S.K. LinesWilson Kwong, Chief Executive, Hong Kong Air Cargo TerminalsShamika N. Sirimanne, Director, Division on Technology and Logistics, UN Trade & DevelopmentThe Hong Kong’s NextGen Logistician Award recognises young talent in the logistics industryOver 300 business-matching sessions were arranged, demonstrating Hong Kong’s status as the superconnector and super value-adder between Mainland China and global marketsALMAC: https://www.almac.hk/main/en/Media enquiriesYuan Tung Financial Relations:Agnes Yiu    Tel: (852) 3428 5690     Email: ayiu@yuantung.com.hkEdmund Choi  Tel: (852) 3428 2360     Email: echoi@yuantung.com.hkHKTDC Communications & Public Affairs Department:Stanley So   Tel: (852) 2584 4049     Email: stanley.hp.so@hktdc.orgClayton Lauw Tel: (852) 2584 4472     Email: clayton.y.lauw@hktdc.orgHKTDC Media Room: http://mediaroom.hktdc.com Copyright 2024 ACN Newswire via SeaPRwire.com.

More

GMG Reaches Market Commercialisation Milestone on Energy Savings Coating THERMAL-XR(R)

Brisbane, Queensland, Australia--(ACN Newswire via SeaPRwire.com - November 19, 2024) - Graphene Manufacturing Group Ltd. (TSXV: GMG) (OTCQX: GMGMF) ("GMG" or the "Company") is pleased to provide a business update on the commercialisation progress of THERMAL-XR® Powered by GMG Graphene.SINGAPORE GREEN BUILDING COUNCIL PRODUCT APPROVALThe Singapore Green Building Council has approved THERMAL-XR to be certified as a Singapore Green Building Product (SGBP) under the category of Mechanical - ACMV - Coil Coating. It is the first thermal air conditioning coating to be approved as a SGBP - please see the attached link: https://web.sgbc.online/public/product/certificate/5/46/495/8867/2978.The SGBP Certification Scheme is one of the key standards and benchmarks for green building products in the building and construction industry. Products and materials certified as a SGBP are highly recognised under the Green Mark Certification Scheme, Singapore's national green building rating tool administered by the Building and Construction Authority (BCA), which allows certified products to accrue points that count towards a project's Green Mark rating. The more highly rated a product is under the SGBP Certification Scheme (i.e., the more ticks it has achieved), the more points are awarded towards the Green Mark rating.The SGBP Certification Scheme is also widely accepted by regional green building rating tools for its coverage of products' sustainability performance. Examples include GreenRE, a rating tool set up by the Real Estate & Housing Developments' Association (REHDA) of Malaysia, and LOTUS, Vietnam Green Building Council's rating tool. The SGBP Certification Scheme complies with many of the requirements in ISO 14024 Environmental labels and declarations - Type I environmental labelling.Figure 1To view an enhanced version of this graphic, please visit:https://images.newsfilecorp.com/files/8082/230564_97152fedf493f854_001full.jpgThe benefits of SGBP Certification include:FOR PRODUCT SUPPLIERS:Analysis of your product's sustainability performance by experts and certification by a credible sourceOpportunity and insight into how to further develop your products to be more sustainableGreater awareness of your product for use in our current and future buildingsFOR DESIGNERS/ SPECIFIERS:An overview of products that are certified sustainableAn understanding of how a product stacks up against others in terms of their sustainability performanceEasier decision-making when choosing more sustainable productsFOR BUILDERS/ OWNERS:An overview of products that are certified sustainableData around the environmental properties of the products you useA unique selling point for your building projectsFOR TENANTS/ OCCUPANTS:An understanding of how sustainable the spaces you live and work in areHealth benefits of living/working in a greener buildingOnce a product is certified, SGBC will issue the product a certificate. Only certified products will be listed on the SGBP Certification Directory, which is maintained on the Singapore Green Building Council's website. This Interactive Directory is actively used by building industry professionals such as consultants, contractors, building developers and owners. Stakeholders can demand that products/ materials used for a building are SGBP certified. Certified products can gain credits under various green building rating tools.USA EPA PRE-MANUFACTURE NOTICE SUBMISSION MADEGMG and Nu Calgon have submitted a Pre-Manufacture Notice ("PMN") in conjunction with its USA Environmental Protection Agency's ("EPA") application to import and sell THERMAL-XR® in the USA. The PMN application is expected to be approved in less than 12 months. The PMN application covers the use of the coating in various application methods in various industrial applications.GMG's Managing Director and CEO, Craig Nicol, commented: "The SGBP Certification is highly welcomed and comes after many years of working with our coating and carrying out many demonstration projects in Singapore with our distribution and coating partners. We also welcome the progress on the EPA submission with our Nu Calgon distribution partner."GMG's Chairman and Director, Jack Perkowski, commented: "THERMAL-XR® being recognised as a Singapore Green Building Product is a very good sign of all the hard work GMG has done there over the years. The USA HVAC after market for coatings is a substantial opportunity for GMG and so it is good to see the progress on the EPA submission as well."About THERMAL-XR® powered by GMG Graphene:THERMAL-XR® COATING SYSTEM is a unique method of improving the conductivity of corroded heat exchange surfaces and improving and maintaining the performance of new units at peak levels. The process coats and protects heat exchange surfaces while improving and rebuilding the lost corroded thermal conductivity and increasing the heat transfer rate by leveraging the physics of GMG Graphene, resulting in an efficiency improvement and a potential power reduction.THERMAL-XR RESTORE® is powered by GMG Graphene. PATENT PENDINGAbout GMG www.graphenemg.comGMG is a clean-technology company which seeks to offer energy saving and energy storage solutions, enabled by graphene, including that manufactured in-house via a proprietary production process. GMG has developed a proprietary production process to decompose natural gas (i.e. methane) into its elements, carbon (as graphene), hydrogen and some residual hydrocarbon gases. This process produces high quality, low cost, scalable, 'tuneable' and low/no contaminant graphene suitable for use in clean-technology and other applications.The Company's present focus is to de-risk and develop commercial scale-up capabilities, and secure market applications. In the energy savings segment, GMG has focused on graphene enhanced heating, ventilation and air conditioning ("HVAC-R") coating (or energy-saving coating), lubricants and fluids.In the energy storage segment, GMG and the University of Queensland are working collaboratively with financial support from the Australian Government to progress R&D and commercialization of graphene aluminium-ion batteries ("G+AI Batteries").GMG's 4 critical business objectives are:Produce Graphene and improve/scale cell production processesBuild Revenue from Energy Savings ProductsDevelop Next-Generation BatteryDevelop Supply Chain, Partners & Project Execution CapabilityFor further information please contact:Craig Nicol, Chief Executive Officer & Managing Director of the Company at craig.nicol@graphenemg.com, +61 415 445 223Leo Karabelas at Focus Communications Investor Relations, leo@fcir.ca, +1 647 689 6041Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accept responsibility for the adequacy or accuracy of this news release.Cautionary Note Regarding Forward-Looking Statements This news release includes certain statements and information that may constitute forward-looking information within the meaning of applicable Canadian securities laws. Forward-looking statements relate to future events or future performance and reflect the expectations or beliefs of management of the Company regarding future events. Generally, forward-looking statements and information can be identified by the use of forward-looking terminology such as "intends", "expects" or "anticipates", or variations of such words and phrases or statements that certain actions, events or results "may", "could", "should", "would" or will "potentially" or "likely" occur. This information and these statements, referred to herein as "forward‐looking statements", are not historical facts, are made as of the date of this news release and include without limitation, the receipt, timing and nature of approval by the EPA of the PMN application and the opportunity represented by the USA HVAC after market for coatings. Such forward-looking statements are based on a number of assumptions of management, including, without limitation, assumptions regarding that the EPA will approve the PMN application and on the timing anticipated, that the content of the EPA's approval will be as anticipated, and that the USA HVAC after market for coatings is a substantial opportunity for the Company. Additionally, forward-looking information involves a variety of known and unknown risks, uncertainties and other factors which may cause the actual plans, intentions, activities, results, performance or achievements of GMG to be materially different from any future plans, intentions, activities, results, performance or achievements expressed or implied by such forward-looking statements. Such risks include, without limitation: that the EPA will not approve the PMN application on the timing anticipated or at all, that the content of the EPA's approval will not be as anticipated, that the USA HVAC after market for coatings is not a substantial opportunity for the Company, risks relating to the extent and duration of the conflict in Eastern Europe and its impact on global markets, the volatility of global capital markets, political instability, the failure of the Company to obtain regulatory approvals, attract and retain skilled personnel, unexpected development and production challenges, unanticipated costs and the risk factors set out under the heading "Risk Factors" in the Company's annual information form dated October 3, 2024 available for review on the Company's profile at www.sedarplus.ca.Although management of the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements or forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements and forward-looking information. Readers are cautioned that reliance on such information may not be appropriate for other purposes. The Company does not undertake to update any forward-looking statement, forward-looking information or financial out-look that are incorporated by reference herein, except in accordance with applicable securities laws. We seek safe harbor.To view the source version of this press release, please visit https://www.newsfilecorp.com/release/230564 Copyright 2024 ACN Newswire via SeaPRwire.com.

More

JBM Healthcare Announces FY2025 Interim Results

KEY HIGHLIGHTS- Revenue up by 22.1% to HK$399.0 million- Gross profit increased by 20.3% to HK$205.9 million- Consolidated profit attributable to equity shareholders grew by 53.4% to HK$95.9 million- Interim dividend of HK5.50 cents per share, up by 59.4% year-on-year- Flagship proprietary brands Ho Chai Kung and Po Chai Pills achieved robust growth through effective integrated sales and marketing strategies- Concentrated Chinese medicine granules (“CCMG”) business displayed solid growth momentum, contributing to operational performanceHONG KONG, Nov 19, 2024 - (ACN Newswire via SeaPRwire.com) - JBM (Healthcare) Limited ("JBM Healthcare" or the "Company"; Stock Code: 2161, together with its subsidiaries, the "Group"), a leading branded healthcare products marketer and distributor in Hong Kong, today announced the interim results of the Group for the six months ended 30 September 2024 ("FY2025 Interim" or the "Reporting Period").During the Reporting Period, the Group's branded healthcare business delivered exceptional performance. Revenue reached HK$399.0 million, representing a notable period-on-period growth of 22.1%. The Group's gross profit for the same period reached HK$205.9 million, representing an increase of 20.3%. In the first half of fiscal year 2025, the consolidated profit attributable to equity shareholders grew by 53.4% to HK$95.9 million.The Group's robust performance was propelled by the outstanding sales from flagship brands, with Ho Chai Kung leading in branded medicines and Po Chai Pills excelling in proprietary Chinese medicines. Additionally, the CCMG business of the Group sustained solid growth momentum. These results reflect the successful execution of integrated sales and marketing strategies across both offline and online channels, effectively capitalising on expanding demand for consumer healthcare products in Hong Kong, Macau, and Greater Bay Area.The Board has declared the payment of an interim dividend of HK5.50 cents per share, up by 59.4% year-on-year.Notable Growth Across SegmentsIn the branded medicines business, sales revenue grew by 23.9%, which was led by sustained momentum in Ho Chai Kung product sales. As a leading household name in over-the-counter pain relief and fever medications, Ho Chai Kung strengthened its market presence through targeted brand marketing and sales initiatives. The brand enhanced its appeal to young consumers by ramping up its social media efforts, particularly on platforms like Xiaohongshu and Douyin, aligning with digital trends and expanding its reach among Mainland Chinese youth.In the proprietary Chinese medicines segment, sales rose 17.9%, driven by the strong performance of Po Chai Pills and the sustained growth of the CCMG business. As part of its ongoing strategy to boost brand awareness, Po Chai Pills strategically aired its TV commercial featuring renowned singer Ivana Wong as a brand ambassador during peak sales periods to enhance consumer recall. Additionally, Po Chai Pills gained further visibility by title-sponsoring the popular TVB program "Midlife Sing & Shine! 3", reaching a broad television audience.In the health and wellness products segment, sales revenue increased by 38.9%, driven by the steady growth of Oncotype DX Breast Cancer Recurrence Score Test (“Oncotype DX”), along with expanded product offerings and enhanced marketing efforts targeting the mass wellness market. Oncotype DX has gained increasing recognition among healthcare professionals in Hong Kong and Macau, particularly in the public sector. To further support growth, the Group launched a patient care program with the Hong Kong Breast Cancer Foundation, enabling public hospital patients to receive reimbursement for the test if it indicates the need for additional chemotherapy.Cross-Border E-Commerce and TCM Sector ExpansionThe Group has made positive strides in expanding its online presence, particularly on cross-border e-commerce platforms, while strategically positioning itself to capitalise on the growing traditional Chinese medicine ("TCM") sector in Hong Kong and the Greater Bay Area. Flagship stores for Ho Chai Kung, Po Chai Pills, CCMG, and Jacobson Medical have been launched on the Tmall Global, strengthening brand presence and extending reach in Mainland China. These initiatives have significantly enhanced brand visibility and image among Mainland Chinese consumers.Mr. Patrick Wong, Chief Executive Officer of JBM Healthcare, commented, "Despite a challenging retail environment during the Reporting Period, the Group delivered strong performance driven by our robust portfolio, effective brand management, and enhanced commercial execution, with particular success in our flagship proprietary brands.""Looking ahead, we remain optimistic and confident in the Group's strategic positioning for sustained growth. Key market dynamics, including sedentary lifestyles, increasing health consciousness driven by improving living standards, and aging populations, are collectively fueling growth momentum in consumer healthcare demand. We are committed to operational excellence and growth strategies that focus on enriching our product portfolio, strengthening commercial capabilities, and broadening our sales platforms and geographic reach."About JBM (Healthcare) Limited (Stock Code: 2161)JBM Healthcare is a Hong Kong-based company that markets and distributes branded healthcare products across Greater China, Southeast Asia, and other select countries. The Group is a distinctive player in the sector with marketing expertise and heritage in pharmaceuticals that prioritises product efficacy and quality to meet consumers' healthcare needs. As a renowned healthcare brand operator in Hong Kong, the Group carries a wide-ranging portfolio of branded healthcare products comprising branded medicines, proprietary Chinese medicines, and health and wellness products, which include well-recognised household brands such as Po Chai Pills, Ho Chai Kung Tji Thung San, Contractubex, Mederma for Kids, Tong Tai Chung Woodlok Oil, Flying Eagle Woodlok Oil, Saplingtan, Shiling Oil and Konsodona Medicated Oil. JBM Healthcare has been a constituent stock of the MSCI Hong Kong Micro Cap Index since 27 May 2021. For more details about JBM Healthcare, please visit: www.jbmhealthcare.com.hk Copyright 2024 ACN Newswire via SeaPRwire.com.

More

Fourth Paradigm’s Platform Business Grew by 50.2% in the First Three Quarters

HONG KONG, Nov 19, 2024 - (ACN Newswire via SeaPRwire.com) - Beijing Fourth Paradigm Technology Co., Ltd. (“Fourth Paradigm” or the “Company”, Stock Code: 6682.HK) announced its core business update for the period ended September 30, 2024. The Company achieved a revenue of RMB3.2 billion in the first three quarters of this year, marking a 26.1% year-on-year increase. The gross profit reached RMB1.4 billion, showing a 12.5% year-on-year growth.The company's core business, the Sage AI platform, has shown significant growth, generating a revenue of RMB2.2 billion, representing a year-on-year increase of 50.2%. According to data from International Data Corporation (IDC), a reputable international research institution, Fourth Paradigm has consistently ranked first in the machine learning platform sector in China in terms of market share for six consecutive years.The Company continues to enhance key capabilities within the Sage AI platform, such as AI Agent and GPU resource pooling, and has successfully achieved end-to-end capabilities in computing power, platform infrastructure, model development, and application deployment. Through the "Sage Inside" model, Fourth Paradigm has efficiently developed over 40 artificial intelligence products, significantly expanding the boundaries of industrial ecosystems and empowering various industries with artificial intelligence applications.In the first three quarters, Fourth Paradigm has seen a continual improvement in customer service depth and user engagement. The Company has focused on industries such as transportation, energy and power, finance, and telecommunications, with a total of 224 corporate users, including 98 lighthouse users. On average, lighthouse users, namely Global Fortune 500 companies and publicly listed companies, contribute approximately RMB14.9 million in revenue.The core business grew by 50.2%, with the "Sage Inside" model and 40 AI products driving long-term growthThe Fourth Paradigm Sage AI platform serves as the nucleus of all operations of the Company. In the first three quarters, the industry-leading large model development and management platform, "Sage AI Platform 5.0", has achieved end-to-end capabilities in computing power, platform infrastructure, model development, and application deployment. The AI platform continues to optimize key capabilities such as AI Agents, GPU resource pooling, and unified model hosting. It also integrates generative AI with various ecosystem products and solutions to advance the deployment of generative AI.For instance, AI Agent has enhanced the precision of complex reasoning and execution, covering the entire lifecycle from large model Agent design, development, commissioning, deployment, operational analysis, to self-learning optimization, providing a stable and reliable support for Agent production applications. Additionally, the Company has further improved AI Coding products in terms of enterprise-side product functionality and application effectiveness, thus reducing development barriers, enhancing code development efficiency, and transforming enterprise software interaction methods to scale up AI application development.The Company continues to innovate AI business application models, scaling the construction of AI products applicable to various scenarios through the "Sage Inside" model. As of September 30, 2024, under this model, the Company has developed over 40 AI products, including solutions like intelligent mouse solution, intelligent meeting solution, vGPU, AI Data Foundry, large model toolchains, the integrated platform "Tianshu" for search, advertising and promotion, Model Hub for large model hosting, intelligent number query, AI digital human video generation platform, Smart Archive 2.0 for document digitization management, AI+5G video marketing, AI quality inspection systems, 3D scanning and modeling devices, and many more. These AI products have been widely applied in enterprises, expanding the industry coverage of the Sage AI platform and providing long-term growth impetus for the Company's future business development.AI Agent empowers multiple solutions, scaling the development of industry large models with demonstrative significanceDuring the period, Fourth Paradigm further expanded the coverage and penetration of its technology and products across multiple industries and scenarios. In terms of product feature iterations, the Company integrated AI Agent capabilities into AIGS Builder, AIGS CodeX, and various intelligent hardware solutions, enabling products to achieve more complex reasoning and execution capabilities. Moreover, the AI Agent based on reinforcement learning technology has formed a self-learning loop, where the more users engage with it, the stronger the model's reasoning and execution capabilities become.During the period, the Company collaborated with lighthouse users to jointly create a set of industry-leading large models with demonstrative significance, accelerating the widespread application of AI technology across various industries.In the field of transportation, the Company partnered with a globally leading port group to build a large model for port supply chain management, providing intelligent capabilities for the transformation of comprehensive port supply chain services and promoting sustainable applications of large models in the port and maritime industries and related businesses. For academic translation, the Company collaborated with Modern Press to establish the first professional publishing large model in China, elevating the translation quality of large models to academic publication standards. Compared to general-purpose large models in professional book translations, this large model showed an improvement of over 30% in BLEU (BLEU: a mainstream evaluation standard for machine translation, primarily assessing translation quality by comparing the similarity between machine-translated results and human reference translations), meeting the high-accuracy translation demands of academic verticals. Copyright 2024 ACN Newswire via SeaPRwire.com.

More

健倍苗苗公布二零二五财年中期业绩 纯利飙升53.4%至95.9百万港元

业绩亮点- 收益增长22.1%至约4.0亿港元- 毛利上升20.3%至约2.1亿港元- 权益持有人应占综合溢利增长53.4％至95.9百万港元- 中期股息每股5.50港仙，同比增长59.4%- 凭借有效的整合及营销策略，旗舰品牌何济公及保济丸实现强劲增长- 浓缩中药颗粒剂业务展示稳健增长势头，为经营业绩带来贡献香港, 2024年11月19日 - (亚太商讯 via SeaPRwire.com) - 健倍苗苗（保健）有限公司 （「健倍苗苗」或「公司」；股份代号：2161，连同其附属公司统称「集团」）为香港品牌保健品的领先营销商及分销商，集团今天公布截至二零二四年九月三十日止六个月（「二零二五财年中期」或 「报告期」）的中期业绩。报告期内，集团的品牌医疗保健业务表现出色。收益总额录得约4.0亿港元，较去年同期显著增长22.1%。集团的毛利为2.1亿港元，同比增长20.3％。于二零二五年财年上半年，权益持有人应占综合溢利增长53.4% 至95.9百万港元。集团优秀的表现主要受惠于集团旗舰品牌的强劲销售势能，尤其是品牌药分部的何济公和品牌中药分部的保济丸。此外，集团的浓缩中药颗粒业务持续增长也提供进一步支持。这样的亮眼表现反映集团的线下及线上渠道销售及营销策略行之有效，从而把握品牌消费保健产品于香港、澳门及大湾区市场的增长潜力。董事会宣派中期股息每股5.50港仙，同比增长59.4%。各分部均录得显著增长品牌药分部的销售收益增长23.9％，主要受惠于何济公产品持续的销售势头。作为止痛退烧药非处方类别中领先的家用品牌，何济公透过精准品牌营销及销售计划巩固其市场占有率。该品牌加强社交媒体运营，特别是在小红书及抖音等平台上，以提高其对年轻群体的吸引力，顺应数字化趋势，并扩大其在中国内地年轻消费者当中的影响力。品牌中药分部销售收益增长17.9％，主要受保济丸的强劲表现及浓缩中药颗粒业务的持续增长所带动。作为提升品牌知名度的持续策略其中一环，保济丸在销售高峰期间策略性地播出由知名歌手王菀之担任品牌大使的电视广告，以加深消费者的印象。此外，保济丸亦成为热门TVB节目《中年好声音3》的冠名赞助商，向广大电视观众进一步宣传品牌。健康保健品分部的销售收益增长38.9％。该增长主要受Oncotype DX安可待乳癌基因表现检测 ("Oncotype DX") 的稳步增长，加上集团扩大产品组合及加强针对大众健康市场的营销力度所带动。Oncotype DX在香港及澳门的医疗专业人士中已获得越来越高的认可度，特别是在公营界别。为进一步支持增长，集团与香港乳癌基金会合作推出一项患者护理计划，向检测结果显示需要接受进一步化疗的公立医院病人提供费用报销。扩展跨境电子商务及传统中药行业集团在拓展线上业务方面取得进展，尤其是跨境电子商务平台，同时策略性地进行部署，把握香港及大湾区持续增长的传统中药行业机遇。此外，集团就何济公、保济丸、浓缩中药颗粒产品及雅各臣药业在已于天猫国际开设旗舰店，以加强品牌知名度及扩大在中国内地的覆盖范围。此等措施显著提升集团于内地消费者群中的品牌知名度及形象。健倍苗苗行政总裁黄一伟先生表示：「尽管报告期内零售环境充满挑战，该集团仍然通过丰富的产品组合、有效的品牌管理及强大的商业执行实现斐然成绩，尤其是在我们的旗舰品牌方面取得了显著成功。展望未来，我们对集团的策略定位持乐观态度，并对持续增长充满信心。多个主要市场因素，包括久坐的生活方式、生活水平提升带来更高健康意识及人口老龄化，共同促进了消费者健康需求的增长动力。我们致力于卓越营运及增长策略，专注于丰富产品组合、加强商业能力以及扩大销售平台及地理覆盖范围。」有关健倍苗苗（保健）有限公司 （股份代号：2161）健倍苗苗是设于香港的品牌医疗保健品推广及分销公司，产品据点遍及大中华、东南亚及其他选定国家。集团拥有丰富的行销专业知识并具备深厚的制药背景，秉承产品功效和品质至上的优良传统，在行业内定位独特，致力于满足消费者的保健需要。作为本地领先的品牌医疗保健品运营商，集团拥有一广泛系列品牌医疗保健品，包括品牌药、品牌中药及健康保健品，其中包括「保济丸」、「何济公止痛退热散」、「德国秀碧除疤膏」、「美德玛宝儿除疤啫喱」、「唐太宗活络油」、「飞鹰活络油」、「十灵丹」、「十灵油」及「镇痛霸祛风活络油」等家喻户晓的传统品牌。而自2021年 5月27日，集团获纳入 MSCI 香港微型股指数成份股。有关集团详情，请浏览：www.jbmhealthcare.com.hk Copyright 2024 亚太商讯 via SeaPRwire.com.

More

第四范式前三季度平台业务增长50.2% 超40款AI产品提供强增长动力

香港, 2024年11月19日 - (亚太商讯 via SeaPRwire.com) - 北京第四范式智能技术股份有限公司（“第四范式”或“公司”，股份代号：6682.HK）发布2024年截至9月30日期间核心业务进展，今年前三季度营收人民币32.18亿元，同比增长26.1%；毛利人民币13.50亿元，同比增长12.5%。公司核心业务先知AI平台业务显著增长，收入人民币21.71亿元，同比增长50.2%。据国际权威研究机构国际数据公司（“IDC”）报告数据显示，第四范式连续六年稳居中国机器学习平台市场份额第一。公司持续优化先知AI平台中AI Agent、GPU资源池化等多项关键能力，已实现算力层、平台层、模型层、应用层等端到端的能力供给。并通过“先知 Inside 模式”，高效打造了40馀款人工智能产品矩阵，极大拓展产业生态及人工智能赋能千行万业的应用边界。前三季度第四范式客户服务深度和用户粘性不断提升，继续深耕交通运输、能源电力、金融、运营商等重点行业，期间企业总用户数224个，标杆用户群体平均营收贡献为人民币1,487万元（标杆用户：全球财富500强企业或上市公司）。核心业务增长50.2%，“先知Inside模式”40款AI产品为长期增长提供动力第四范式先知AI平台，是公司所有业务的内核。前三季度，第四范式行业大模型开发及管理平台“先知AI平台5.0”已实现算力层、平台层、模型层、应用层等端到端的能力供给。先知AI平台持续优化其AI Agent、GPU资源池化、模型统一纳管等多项关键能力，同时开展生成式AI与各类生态产品、解决方案的深度结合，推动生成式AI落地进程。例如，AI Agent 提升了复杂推理及执行的精准度，并覆盖大模型Agent设计、开发、调试、发布、运营分析、自学习优化的全流程，为Agent生产应用提供稳定可靠保障；此外，公司也进一步提升AI Coding类产品在企业侧产品功能及应用效果，降低开发门槛、提升代码开发效率，实现了改造企业软件交互方式、及规模化打造AI应用的目标。公司继续创新AI商业应用模式，通过“先知Inside模式”，规模化构建可应用不同场景的人工智能产品，截至2024年9月30日，在该模式下，公司已累计打造40馀款人工智能产品，囊括智慧滑鼠解决方案、智能会议解决方案、vGPU、AI Data Foundry、大模型工具链、搜广推一体化平台“天枢”、大模型纳管平台Model Hub、智慧问数、AI数位人视频合成平台、文档数字化管理平台Smart Archive 2.0、AI+5G视频营销、AI质检系统、三维扫描建模设备等多款人工智能产品，在企业中形成了规模化应用，拓宽先知AI平台的行业覆盖空间，为公司未来业务发展提供长期增长动力。AI Agent赋能多款解决方案，规模化打造标杆意义行业大模型本期间，第四范式进一步拓展技术、产品在多行业及场景的覆盖度及渗透率。在产品功能迭代方面，公司将AI Agent能力加入到AIGS Builder、AIGS CodeX、及多款智能硬体解决方案中，让产品获得解决更加复杂的推理和执行能力。且基于强化学习技术的AI Agent形成了自学习闭环，用户使用越多，模型推理能力越强，执行能力越准确。本期间，公司携手标杆用户联合打造了一批具有示范意义的行业大模型，并加速推动人工智能技术在千行百业的规模化应用。在交通运输领域，与全球领先的港口集团合作构建港口供应链大模型，为实现港口供应链综合服务转型提供智能化能力输出，推动大模型在港航领域及周边业态的可持续应用发展；在学术翻译领域，公司与现代出版机构合作共建国内首个出版专业大模型，使大模型的翻译水准达到学术出版级别，较通用大模型在专业书籍的 BLEU（BLEU：机器翻译的主流评估标准，主要通过对比机器翻译结果与人工参考翻译之间的相似度来评价翻译质量）提升 30% 以上，满足学术垂直领域的高准确度翻译需求。 Copyright 2024 亚太商讯 via SeaPRwire.com.

More

GTDC Summit APJ Highlights IT Distributors’ Roles in Navigating Digital Transformation

SINGAPORE, Nov 19, 2024 - (ACN Newswire via SeaPRwire.com) - Top executives from the IT distribution and technology vendor sectors convened today at the inaugural GTDC APJ-Summit 2024 to discuss the current position and future outlook of these critical communities. The Summit underscored the essential role distributors play in scaling emerging technology sales and adoption and developing new opportunities through digital marketplaces and alliances with hyperscalers.Frank Vitagliano emphasizes the rising value of distribution as he opens the inaugural GTDC Summit APJ.The vast scale and economic and cultural diversity of the APJ region necessitates local expertise. As vendors adopt varied approaches to managing channels, they are increasingly relying on distributors to support emerging markets while focusing internal resources on more mature communities. This strategy provides greater reach, especially in areas where direct coverage would be inefficient, and represents a broader shift towards optimizing orchestration through partnerships."Distributors are ideally positioned to bridge complex regional and in-country dynamics, with local representatives who understand cultural and language nuances to best support the objectives of their vendors and partners. Focusing on enablement programs and relationship-building allows distributors to create strategic value that ensures the successful adoption of advanced technologies across diverse APAC markets," said Frank Vitagliano, CEO, GTDC.IT spending across Southeast Asia and India is accelerating, driven by SMBs embracing digital transformation through cloud software, cybersecurity, and logistics investments. This digital shift generates increased demand for cloud infrastructure, managed services, and robust security solutions. Simultaneously, according to IDC, AI adoption is further fueling the region's technological momentum, with spending in this area expected to reach $78 billion by 2027, with a 25% annual growth rate. Distributors empower those advances while transforming the customer experience and operational efficiencies across these key sectors.Vendors also rely on distributors to meet the rising demand for AI, sales, and technical support as the region struggles with talent shortages, especially in these key areas.Distributors are meeting these demands while unlocking new opportunities using advanced data analytics. Channelnomics CEO Larry Walsh emphasized these organizations' capabilities for identifying "white space" and expanding partner networks. "While data provides direction, its true value lies in transforming insights into actionable strategies for partners. Distributors are pivotal in redefining go-to-market models, guiding partners through business-enhancing engagements and maximizing channel potential."Other Memorable Highlights from Summit APJThe summit focused on the changing dynamics of IT distribution, emphasizing the increasing importance of Southeast Asia and India in the global tech sector. Key sessions included:John Marrett from the EIU spoke to the rapidly expanding marketplace and described the ways technical innovation is changing businesses and communities. From shifts in monetary and fiscal policies to currency fluctuations and international financial institutions' activities, he highlighted the impact of these movements on the APJ's IT community.Avneesh Saxena of IDC showed how innovation affects global IT relationships and creates new opportunities for the channel. He emphasized the key industry trends, barriers, and investments and explored the evolving dynamics between partners, vendors, and distributors.Larry Walsh of Channelnomics examined the often-overlooked pieces of the vendor-distributor relationship and hit on other key findings of their recently released study with GTDC. Focused on the Asia-Pacific region, the new report shows vendors how to maximize the value of their distribution relationships.Vitagliano also moderated a panel discussion with senior distribution executives, including William Ong,VST ECS;V.S. Hariharan, Redington Limited; Luis Lourenco, Ingram Micro; Jaideep Malhotra, TD SYNNEX; and Patrick Aronson, Westcon-Comstor. Panelists highlighted how regional distributors are innovating and creating programs that facilitate the adoption of new technologies, optimize go-to-market strategies and enhance other business activities.The council's next global event GTDC Summit North America, February 19th -20th, 2025, at the Mission Pacific & Seabird Resort in Oceanside, CA. More details will be available soon.About the GTDC The Global Technology Distribution Council is the industry consortium representing the world's leading tech distributors. GTDC members drive an estimated $160 billion in annual worldwide sales of products, services and solutions through diverse business channels. GTDC conferences support the development and expansion of strategic supply-chain partnerships that continually address the fast-changing marketplace needs of vendors, end customers and distributors. GTDC members include AB S.A (WSE: ABPL), Arrow Electronics (NYSE: ARW), CMS Distribution, Computer Gross Italia (MI: SES), D&H Distributing, ELKO, Esprinet (PRT.MI), Exclusive Networks (EPA: EXN), Exertis, Infinigate, Ingram Micro (NYSE: INGM), Intcomex, Logicom (CSE: LOG), Mindware, Redington Limited (BSE/NSE: Redington), Siewert & Kau, SiS Technologies (HKSE:0529), Tarsus, TD SYNNEX (NYSE: SNX), TIM AG, VSTECS Holdings and Westcon-Comstor.GTDC MEDIA CONTACT: Anita LussenburgTel +31621585878Mail: alussenburg@gtdc.euSOURCE: Global Technology Distribution Council Copyright 2024 ACN Newswire via SeaPRwire.com.

More

德国将向乌克兰交付AI控制的无人机 “`

(SeaPRwire) -   德国国防部长鲍里斯·皮斯托里乌斯表示，“迷你金牛座”无人机不受GPS干扰的影响 德国国防部长鲍里斯·皮斯托里乌斯宣布，德国将向乌克兰交付4000架人工智能控制的“自杀式”无人机。这些无人机被称为“迷你金牛座”，是对柏林远程巡航导弹的隐喻，据报道，它们不受干扰和其他禁用措施的影响。 据《世界报》(Die Welt)援引皮斯托里乌斯在巴伐利亚州施罗本豪森的一次活动上的讲话称，这些武器可以“让敌人的电子无人机防御失效”，并且可以“绕过它”。他补充说，这些无人机可以飞到30或40公里外的“腹地，然后攻击指挥所、后勤枢纽和其他目标”，称它们是乌克兰军队的“一项重要额外资产”。 《图片报》(Bild)周一早些时候报道称，软件公司Helsing已于9月份与乌克兰国防部签署了HX-2 Karma无人机的交付合同，该项目将由德国联邦政府资助。 皮斯托里乌斯此前在6月份宣布将向乌克兰交付数千架战斗无人机，但当时没有提供更多细节。 HX-2 Karma无人机被昵称为“迷你金牛座”——这是对德国制造的空射金牛座巡航导弹的指称。《图片报》表示，它的射程是乌克兰军方使用的常规自杀式无人机的四倍以上。它还可以在无线电连接中断的情况下飞向目标，这意味着它的命中率比传统的、人工控制的无人机要高得多。 报道称，从12月开始，每月将交付数百架。 乌克兰曾多次要求德国提供金牛座空射远程巡航导弹。然而，尽管德国现已垮台的执政联盟的一些成员以及一些资深反对派人士反对，但总理奥拉夫·朔尔茨仍然拒绝提供。 朔尔茨为拒绝向乌克兰军队提供金牛座导弹的理由是，此举将使德国成为这场冲突的直接参与者。 周一，当被问及在报道称美国将允许乌克兰使用其导弹对俄罗斯境内进行远程袭击后，总理是否会解除禁令时，皮斯托里乌斯表示，这一决定“目前不会改变我们的评估”。他补充说，远程导弹不会成为乌克兰战场上的“改变游戏规则者”。 本文由第三方内容提供商提供。SeaPRwire (https://www.seaprwire.com/)对此不作任何保证或陈述。 分类: 头条新闻,日常新闻 SeaPRwire为公司和机构提供全球新闻稿发布，覆盖超过6,500个媒体库、86,000名编辑和记者，以及350万以上终端桌面和手机App。SeaPRwire支持英、日、德、韩、法、俄、印尼、马来、越南、中文等多种语言新闻稿发布。

More

可持续内生增长 晶科电子处价值洼地

香港, 2024年11月19日 - (亚太商讯 via SeaPRwire.com) - 伴随四季度港股IPO市场景气度回升，年度 「超购王」晶科电子（2551.HK）的凭借惊艳表现，成为市场瞩目的焦点。高达5,678倍的公开发售认购倍数，不仅打破了科技类企业港股IPO的历史记录，也让公司成为港股IPO史上仅次于毛记葵涌的唯二超过5,000倍的新股。目前晶科电子股价位于4元区间，仍处价值洼地，看涨未来长期估值。根据公司招股书，未来三年，公司也拟根据业务运营及现金流量状况采用不低于派息年度净利30%的派息率，该派息政策可见公司对于自身盈利能力和可持续发展的信心，进一步奠定了投资者长期持有公司标的的信心。同时，公司能够获得资本市场青睐，与晶科电子领先的行业地位、稳健的基本面及远阔的发展前景密不可分。作为LED智能视觉行业头部企业，公司深入布局高成长性确定性强的优质赛道，技术能力位于全球创新先进行列，在汽车智能视觉、高端照明及新型显示三大高增长的LED细分市场，显现出加速兑现的态势。当前国家以旧换新家电、汽车等政策性补贴加码，全国相关消费热度维持高水平。市场对新型显示的需求显著增加，晶科电子产能全满，业绩额有足够市场支撑。据市场消息，10月晶科电子在汽车智能视觉领域的销售额或将创下新纪录。「LED+」技术赋能，高筑竞争壁垒受益于LED技术进步及LED产品广泛应用，LED智能视觉行业已逐步向「LED+」技术的转变。「LED+」技术将LED技术与电子控制、软件、传感器及光学等相结合，为行业发展设定了新轨迹。根据广东省照明学会的资料，「LED+」技术已成为行业规范，被行业广泛采用，并受机构及实体广泛引用。利用在LED芯片和封装技术方面的前期积累及成就，晶科电子开发出广泛的技术。公司的技术包括涵盖倒装LED技术及先进光电半导体封装技术的基础技术，及针对特定应用领域而开发的特定产品技术。基于独具优势的专有技术，公司持续加强自主研发，形成了一套全面的知识产权保护体系。截至最后实际可行日期，公司在多个国家拥有376项专利，研发成果丰硕。基础技术方面，晶科电子是早期从事倒装LED技术开发的领先公司之一，其基于倒装芯片结构的LED产品，具有热传导能力强、耐用性高、可靠性好及光效高的优势，在行业内始终表现出卓越的性能、高生产良率及高质量。同时，公司掌握多种先进光电半导体封装技术的核心技术，其中包括先进白光封装光转换技术、先进LED集成封装技术及高端LED器件封装技术。针对特定产品的技术方面，于过去几年，晶科电子以先进的基础技术为依托，专注于LED应用关键技术的开发，涵盖汽车智能视觉、高端照明及新型显示。由此，公司成功开发了针对智能车灯、车规级LED器件和模组、高端LED照明及新型显示的多种针对特定产品的技术。后续，晶科电子将专注「LED+」创新，实现技术突破。一方面，持续构建「LED+」核心技术体系，加速前沿技术研发，保持技术先进性。另一方面，将预判市场需求显现节奏，战略性布局传感器、激光雷达、控制器技术，加大对前沿技术和产品的持续研发投入，强化竞争优势。一流客户群助力业务扩张，汽车智能视觉或创新高由于车规级器件、模组以及汽车视觉产品及系统的技术开发要求严苛、设备投资巨大且体系认证门槛较高，汽车智能视觉市场具有较高进入门槛。已经在行业站稳脚跟的晶科电子，凭借卓越的研发实力及稳定的产品质量，形成了稳定客户群。近日，晶科电子获三星电子面向全球合作伙伴颁发的"最佳外驻社"称号及荣获海信授予的"品质改进奖"等。这些奖项充分肯定了晶科电子在2024年度支持客户业务发展中的突出表现和卓越贡献，不仅彰显了晶科电子专业高效的客户服务支持能力，更体现了晶科电子为客户持续创造显著价值的实力。业界的良好声誉和知名度加持下，晶科电子稳步扩大业务规模，与客户构建了长期合作关系。公司的客户及终端用户包括昕诺飞（曾用名飞利浦照明）、三星、松下、丰田合成等国际一线照明公司，以及海信、TCL、创维、长虹、LG及三星等知名电视品牌。此外，公司已与二十余家国内汽车主机厂、汽车品牌及一级供应商建立合作关系，包括吉利汽车、领克、极氪、精灵、路特斯、广汽、长安汽车、理想汽车等行业领导者。随着客户群的不断扩张，近年来，晶科电子业绩节节攀升，实现量与质的双重提升。自2021年至2023年，公司收入从人民币13.88亿元增至18.58亿元，复合年增长率为15.7%；毛利润从人民币2.28亿元增至3.39亿元，复合年增长率为21.9%。2024年前五个月，公司收入、毛利润及经调整净利润分别同比增长35.0%、47.9%及465.3%，优秀盈利能力支撑业绩高成长。消费者节能环保意识的提高，以及利好政策和法规的实施，推动LED智能视觉成为全球各国战略性新兴产业之一。根据灼识咨询预计，全球LED智能视觉行业的市场规模到2028年将增长至2,872亿美元，2023年至2028年的复合年增长率为8.4%。中国拥有全球最大的LED智能视觉产业，预计于2028年，该市场收入将达到人民币6,792亿元，2023年至2028年的复合年增长率为9.1%。高价值、高增长的LED智能视觉行业，孕育着无限的潜力和机遇。汽车智能视觉、高端照明及新型显示正是行业中尚未饱和且最具潜力的市场，堪称最具贝塔效应的黄金赛道。基本面与贝塔的共振，将最大化地释放阿尔法效应，为晶科电子带来高确定性的内生增长，短期股价波动无法影响其市场预期。晶科电子将以穿越周期之力，践行长期主义的精髓。 Copyright 2024 亚太商讯 via SeaPRwire.com.

More

云顶新耀宣布耐赋康(R)在韩国获批 商业化进程再创里程碑

香港, 2024年11月19日 - (亚太商讯 via SeaPRwire.com) - 云顶新耀（HKEX 1952.HK）宣布，韩国食品药品安全部（MFDS）已正式完全批准耐耐赋康(R)（布地奈德肠溶胶囊）的新药上市许可申请，用于治疗罹患原发性免疫球蛋白A肾病变（IgAN）的成人患者（尿蛋白≥1.0g/日或尿蛋白与肌酐比 (UPCR) ≥0.8g/g）。这一批准标志着耐赋康(R)进一步扩大了其在亚洲的市场覆盖范围，并为亚洲IgAN患者提供了创新的对因治疗方案。对此，云顶新耀首席执行官罗永庆表示，非常高兴看到耐赋康(R)在韩国获得完全批准。他指出，"作为全球首个且唯一获得美国食品药品监督管理局（FDA）完全批准的IgA肾病对因治疗药物，耐赋康(R)将为韩国的IgA肾病患者提供全新的对因治疗选择。我们将继续努力推动耐赋康(R)在亚洲地区的可及性和可负担性，满足更多IgA肾病患者对此创新疗法的迫切需求。"作为全球首个获得完全批准的IgA肾病对因治疗药物，耐赋康(R)的临床价值已在国际医学界得到广泛认可。此次韩国获批基于全球III期临床试验NefIgArd研究数据。研究结果显示，与安慰剂相比，耐赋康(R)在多项临床指标上表现出显著优势，包括持久降低蛋白尿下降，减少镜下血尿风险，并在估算肾小球滤过率（eGFR）上显示出临床相关且有统计学意义的治疗获益（p<0.0001）。数据表明，耐赋康(R)能将肾功能衰退风险降低50%，并预计可将疾病进展至透析或肾移植的时间延缓12.8年。研究显示，IgA肾病在亚洲人群中高发，且疾病进展速度更快，亚洲人群进展为终末期肾病的风险相较于其他人群高56%。此次耐赋康(R)在韩国获批，不仅为亚洲IgA肾病患者带来了全新的对因治疗方案，也进一步验证了其在亚洲市场的商业化潜力。此外，耐赋康(R)在韩国获批再次彰显了云顶新耀在全球范围内的商业化能力。今年5月，耐赋康(R)已在中国大陆开出首张处方，并先后在中国澳门、中国香港、新加坡与中国台湾获批。据云顶新耀半年报披露，耐赋康(R)上市后仅一个半月，销售额即达1.673亿元，展现出强劲的市场表现。此次韩国成功获批，不仅进一步体现了市场对耐赋康(R)临床价值和商业潜力的高度认可，也为公司开拓了新的市场空间，带来了重要的收入增长点。值得一提的是，作为填补IgA肾病对因治疗空白的创新药物，耐赋康(R)今年首次参加了国家医保谈判。若顺利进入国家医保目录，将大幅提升其市场覆盖率和患者可负担性，从而加速药品在中国市场的销售放量。业内人士普遍认为，耐赋康(R)有潜力成为中国市场的重磅药物，不仅为云顶新耀的商业化布局注入强劲动力，也进一步增强其在国内外市场的竞争力。 Copyright 2024 亚太商讯 via SeaPRwire.com.

More

“哈马斯作为一个理念无法被武力摧毁”：以色列杀害该组织领导人取得了什么？ “`

(SeaPRwire) -   辛瓦尔被清除一个月后，该地区仍然不稳定，未来看起来黯淡 自从哈马斯在加沙的领导人耶海亚·辛瓦尔在拉法与以色列国防军发生冲突后丧生已经过去一个月了。 尽管这起杀戮是意外的，但却在巴勒斯坦人和他们的支持者中引发了冲击波。以色列将辛瓦尔的清除视为一项重大成就。官员们表示，辛瓦尔离开后，加沙地区和整个地区将变得更加安全。 但是，法塔赫改革派民主派系的新闻发言人迪米特里·迪利亚尼表示，辛瓦尔的清除并没有促进该地区的稳定。 “事实是，清除辛瓦尔只会为更大的动荡埋下伏笔，”他说道。 “这可能会促使该组织采取更加激进的立场。这将加剧本已动荡不安的氛围，进一步加剧地区紧张局势，并可能为西岸巴勒斯坦各派系加强抵抗的时代铺平道路，”迪利亚尼补充道。 迪利亚尼有充分的理由做出这样的假设。甚至在辛瓦尔被清除之前，西岸就已经成为哈马斯、巴勒斯坦伊斯兰圣战组织以及其他在该地区建立据点并与以色列安全部队对抗的组织的肥沃土壤。 该地区还出现了多名单独行动的袭击者，他们在西岸和以色列境内实施或企图实施恐怖袭击。 根据以色列国内情报机构Shin Bet的报告，9月份在西岸和耶路撒冷发生了8起重大袭击事件，而另外72起袭击事件则被该国的安全机构挫败。尽管10月和11月的情报报告尚未公布，但激进组织及其同情者很可能会继续挑战以色列，对平民和军人发动零星袭击。 南部战线的稳定也无从谈起。自2023年10月27日以色列地面入侵加沙以来，其安全部队已经杀害了约373人，只要以色列军队仍然留在该地区，士兵继续以尸体袋的形式回家的大概率是存在的。 然而，稳定和安全远不是以色列在清除辛瓦尔后未能实现的两个目标。另一个目标是该组织的彻底解除武装和消灭。 “这实际上取决于以色列对哈马斯清除的含义，”居住在南非的巴勒斯坦政治分析家瓦利德·塞亚姆说。 “如果他们的意思是削弱该组织的力量，并削弱其军事能力，使其无法再次发射火箭，那么答案是肯定的。如果他们的意思是彻底消灭哈马斯，那么答案是否定的，”他辩称。 塞亚姆说，造成这种情况的原因是哈马斯在巴勒斯坦社会的社会活动根深蒂固。 自从哈马斯于20世纪80年代出现在加沙以来，它一直与援助和帮助联系在一起。他们是分发食物和提供医疗援助的人；他们是筹集资金帮助穷人的人；他们是教育大众的人。对许多巴勒斯坦人来说，这种看法并没有改变。加沙的一些地区仍然严重依赖这个伊斯兰团体。根据最近的一份报告，尽管对该组织的整体支持有所下降，但在巴勒斯坦社会的一些圈子里，对其军事分支卡萨姆旅的支持仍然很强大。 “哈马斯最初是一个慈善组织，通过它，他们获得了如何在非中心化的情况下运作的经验。他们对伊斯兰社会主义的宽容使他们在加沙人民中脱颖而出并积累了信誉，”塞亚姆解释说。 “卡萨姆旅也使用了同样的分散式蓝图。这种结构使他们能够根据地面的战斗需要随时随地进行组合、重组、组建和改革。这就是为什么我们不断听到哈马斯作为一个理念无法被武力摧毁的原因，”他补充道。 哈马斯已经宣布，它打算在3月份选举新的领导人，向以色列和所有怀疑论者发出信号，表明尽管试图损害该组织的活动，但演出将会继续。 潜在的继任者包括总部位于卡塔尔的辛瓦尔的副手哈利勒·阿尔·哈亚、1996年至2017年领导该组织政治局的哈立德·麦沙尔以及耶海亚·辛瓦尔的兄弟穆罕默德。 出于安全原因，当选人的姓名可能会保密，但两位专家都确信，无论谁担任最高职位，都可能会坚持强硬路线。 “新领导人很可能成为与耶海亚·辛瓦尔遗产高度一致的人物，”迪利亚尼说。 “更重要的是，加沙的巨大破坏和平民苦难只会激励哈马斯的下一任领导人采取更强硬的立场，这既是对报复这些损失的责任感，也是对抵抗的承诺。在这种情况下，温和派几乎没有生存空间，而采取更强硬的哈马斯立场以反映以色列政府的立场似乎几乎不可避免，”他补充道。 在一年多的战斗中，以色列的行动夺去了至少43799人的生命，其中许多是老人、妇女和儿童。数千人受伤或下落不明。这场战争还摧毁了加沙的大部分地区。它损坏了重要的基础设施和关键设施，使该地区无法居住。 塞亚姆同意迪利亚尼的这一评估，并表示，加沙的严峻局势加上所有熟悉的“鹰派和鸽派”的清除，将会产生一个真空，伊朗很容易填补这个真空。 这可能会给以色列带来许多问题。多年来，德黑兰一直在向巴勒斯坦武装团体提供外交、财政和军事支持，如果新的哈马斯领导人采取更强硬的立场，那么伊斯兰共和国参与加沙的可能性只会越来越大。如果真是这样，这可能成为以色列不放下武器的借口。 “辛瓦尔的存活为以色列在加沙的军事行动提供了理由。现在他死了，以色列还会拥有这种可信度吗？” 本文由第三方内容提供商提供。SeaPRwire (https://www.seaprwire.com/)对此不作任何保证或陈述。 分类: 头条新闻,日常新闻 SeaPRwire为公司和机构提供全球新闻稿发布，覆盖超过6,500个媒体库、86,000名编辑和记者，以及350万以上终端桌面和手机App。SeaPRwire支持英、日、德、韩、法、俄、印尼、马来、越南、中文等多种语言新闻稿发布。

More